Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


Articles published in Clin Breast Cancer

Retrieve available abstracts of 460 articles:
HTML format



Single Articles


    April 2024
  1. XU D, Wang K, Lin C, Li D, et al
    Can We Do Breast-Conserving Surgery Without Intraoperative Frozen Section of Margin?
    Clin Breast Cancer. 2024;24:191-198.
    PubMed     Abstract available


  2. SFARAD HK, Allweis TM
    Postoperative Complications Following Lumpectomy With Intraoperative X-Ray Radiation Therapy: A Retrospective Comparative Study.
    Clin Breast Cancer. 2024;24:237-242.
    PubMed     Abstract available


  3. NAG S, Berlin L, Hunter K, Bonawitz SC, et al
    Effects of Neoadjuvant Chemotherapy on Autologous and Implant-Based Breast Reconstruction: A Systematic Review and Meta-Analysis of the Literature.
    Clin Breast Cancer. 2024;24:184-190.
    PubMed     Abstract available


  4. DAVEY MG, Tormey S
    Implications of Highly Penetrant Genetic Variants on Breast Surgery.
    Clin Breast Cancer. 2024;24:180-183.
    PubMed     Abstract available


  5. GRZYWACZ VP, Lehrberg AV, Quinn TJ, Zureick AH, et al
    Breast Conserving Therapy for Patients With Prior Cosmetic Implant-Based Breast Augmentation: Outcomes and Comparison Against a Matched Cohort.
    Clin Breast Cancer. 2024;24:227-236.
    PubMed     Abstract available


    March 2024
  6. HUANG JX, Chen YJ, Wang XY, Huang JH, et al
    Nomogram Based on US and Clinicopathologic Characteristics: Axillary Nodal Evaluation Following Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer.
    Clin Breast Cancer. 2024 Mar 13:S1526-8209(24)00078.
    PubMed     Abstract available


  7. BA ZC, Zhang HX, Liu AY, Zhou XX, et al
    Combination of DCE-MRI and NME-DWI via Deep Neural Network for Predicting Breast Cancer Molecular Subtypes.
    Clin Breast Cancer. 2024 Mar 13:S1526-8209(24)00079.
    PubMed     Abstract available


  8. D'ALESSANDRO GS, Munhoz AM, Takeuchi FM, Povedano A, et al
    Is Immediate Breast Reconstruction With a Latissimus Dorsi Myocutaneous Flap Safe for Starting Adjuvant Chemotherapy in Patients With Breast Cancer?
    Clin Breast Cancer. 2024 Mar 10:S1526-8209(24)00076.
    PubMed     Abstract available


  9. CHI Y, Hirachan S, Zhou Y, Bhandari A, et al
    Exploring the Oncogenic Potential of TIMM8A: A Crucial Factor in Breast Cancer Tumorigenesis.
    Clin Breast Cancer. 2024 Mar 6:S1526-8209(24)00049.
    PubMed     Abstract available


  10. STAFFORD L, Sinclair M, Butow P, Hughes J, et al
    Quality of Life Outcomes Associated With Optimization of Treatment by Omitting Radiotherapy in Early Breast Cancer.
    Clin Breast Cancer. 2024 Mar 6:S1526-8209(24)00062.
    PubMed     Abstract available


  11. WEN W, Li Y, Cao X, Li Y, et al
    Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer.
    Clin Breast Cancer. 2024 Mar 6:S1526-8209(24)00060.
    PubMed     Abstract available


  12. MICHAELS E, Chen N, Nanda R
    The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC).
    Clin Breast Cancer. 2024 Mar 6:S1526-8209(24)00061.
    PubMed     Abstract available


  13. JIA X, Wang K, Zhuo Q, Zhao Z, et al
    PARP Inhibitor for Neoadjuvant Therapy in HER2-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Efficacy and Safety.
    Clin Breast Cancer. 2024 Mar 2:S1526-8209(24)00059.
    PubMed     Abstract available


  14. CAKIT BD, Vural SP
    Short-Term Effects Of Dry Heat Treatment (Fluidotherapy) In The Management Of Breast Cancer Related Lymphedema: A Randomized Controlled Study.
    Clin Breast Cancer. 2024 Mar 1:S1526-8209(24)00056.
    PubMed     Abstract available


    February 2024
  15. LI G, Huang Z, Luo H, Tian H, et al
    Photoacoustic Imaging Radiomics to Identify Breast Cancer in BI-RADS 4 or 5 Lesions.
    Clin Breast Cancer. 2024 Feb 29:S1526-8209(24)00055.
    PubMed     Abstract available


  16. WANG T, Wang J, Zhao W, Pan Y, et al
    Clinical Outcomes and Intrinsic Subtypes of Breast Cancer Patients with Single Hormone Receptor-positive Receiving Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2024 Feb 28:S1526-8209(24)00054.
    PubMed     Abstract available


  17. FASOLA CE, Graham E, Sha W, Schepel CR, et al
    Assessment of Postmastectomy Radiation Therapy Receipt by Age and Association With Outcomes in Women With Breast Cancer.
    Clin Breast Cancer. 2024 Feb 28:S1526-8209(24)00057.
    PubMed     Abstract available


  18. DURAN C, Ward RC, Dibble EH
    (18)F-FES PET/CT for Post-Cryoablation Evaluation of Breast Cancer.
    Clin Breast Cancer. 2024 Feb 28:S1526-8209(24)00043.
    PubMed    


  19. MA S, Liu Y, Gao P, Ma R, et al
    Independent Validation of the BRENDA-Score Breast Cancer Prognosis Prediction Tool In Chinese Patients.
    Clin Breast Cancer. 2024 Feb 28:S1526-8209(24)00058.
    PubMed     Abstract available


  20. NISHIMURA R, Fujiki Y, Taira T, Miyaki T, et al
    The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes.
    Clin Breast Cancer. 2024 Feb 22:S1526-8209(24)00051.
    PubMed     Abstract available


  21. SASA S, Inoue H, Nakagawa M, Toba H, et al
    Long-Term Outcomes of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy (N-1 Study, Phase II Trial) in Patients With Operable Breast Cancer.
    Clin Breast Cancer. 2024 Feb 22:S1526-8209(24)00052.
    PubMed     Abstract available


  22. JANSSON M, Lindberg J, Rask G, Svensson J, et al
    Stromal Type I Collagen in Breast Cancer: Correlation to Prognostic Biomarkers and Prediction of Chemotherapy Response.
    Clin Breast Cancer. 2024 Feb 21:S1526-8209(24)00053.
    PubMed     Abstract available


  23. DEBIEN V, Agostinetto E, Bruzzone M, Ceppi M, et al
    The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial.
    Clin Breast Cancer. 2024 Feb 21:S1526-8209(24)00050.
    PubMed     Abstract available


  24. SONDERGAARD SR, Stie M, Bechmann T, Offersen BV, et al
    Through Clinicians Eyes: Use of an In-consultation Patient Decision Aid in Radiation Treatment for Early Breast Cancer. A Qualitative Study.
    Clin Breast Cancer. 2024 Feb 21:S1526-8209(24)00045.
    PubMed     Abstract available


  25. LIAO M, Webster J, Coonrod EM, Weilbaecher KN, et al
    BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in Breast Cancer.
    Clin Breast Cancer. 2024 Feb 16:S1526-8209(24)00047.
    PubMed     Abstract available


  26. DOUGLAS E, Levine B, Ansari A, Ansley K, et al
    Impact of Anti-Estrogen Therapy on Early Cardiovascular Referrals, Tests and Medications in Premenopausal Women with Operable Breast Cancer.
    Clin Breast Cancer. 2024 Feb 16:S1526-8209(24)00044.
    PubMed     Abstract available


  27. JIANG J, Li L, Yin G, Luo H, et al
    A Molecular Typing Method for Invasive Breast Cancer by Serum Raman Spectroscopy.
    Clin Breast Cancer. 2024 Feb 16:S1526-8209(24)00048.
    PubMed     Abstract available


  28. LORENTZEN EH, Minami CA
    Avoiding Locoregional Overtreatment in Older Adults With Early-Stage Breast Cancer.
    Clin Breast Cancer. 2024 Feb 13:S1526-8209(24)00042.
    PubMed     Abstract available


  29. DAI L, Yan W, Ren X, Liu D, et al
    Construction and Validation of a Nomogram Predicting the Overall Survival Benefit of Unilateral Breast Cancer Patients Undergoing Contralateral Prophylactic Mastectomy.
    Clin Breast Cancer. 2024 Feb 7:S1526-8209(24)00039.
    PubMed     Abstract available


  30. SONOLA O
    Re: "Diagnostic Delays in Breast Cancer Among Young Women: An Emphasis on Healthcare Providers" by Costa et al.
    Clin Breast Cancer. 2024 Feb 6:S1526-8209(24)00038.
    PubMed    


  31. PANG J, Yan Z, Tan QT, Allen JC, et al
    Feasibility of Omitting Sentinel Lymph Node Biopsy in an Under-screened Cohort of Breast Cancer Patients With a Premastectomy Diagnosis of Ductal Carcinoma In Situ.
    Clin Breast Cancer. 2024 Feb 5:S1526-8209(24)00040.
    PubMed     Abstract available


  32. XU J, Gan C, Yu S, Yao S, et al
    Analysis of Immune Resistance Mechanisms in TNBC: Dual Effects Inside and Outside the Tumor.
    Clin Breast Cancer. 2024;24:e91-e102.
    PubMed     Abstract available


  33. WANG Y, Peng D, Zhou X, Hu W, et al
    Treatments and Prognosis of the Breast Ductal Carcinoma In Situ.
    Clin Breast Cancer. 2024;24:122-130.
    PubMed     Abstract available


  34. MOKBEL K
    Unlocking the Power of the Homing Phenomenon: Why Breast Conserving Surgery Outshines Mastectomy in Overall Survival.
    Clin Breast Cancer. 2024;24:85-92.
    PubMed     Abstract available


  35. METIN NO, Balci S, Metin Y, Tasci F, et al
    Correlation Between Quantitative Parameters Obtained by Dual Energy Spectral CT and Prognostic Histopathological Factors and Biomarkers in Breast Cancer.
    Clin Breast Cancer. 2024 Feb 1:S1526-8209(24)00037.
    PubMed     Abstract available


  36. REYES A, Sun L, Ha R, Desperito E, et al
    A Comprehensive Assessment of Radial Scars on Core Needle Biopsy in Patients with or without Breast Cancer: Upgrade Rate and Implications on Management.
    Clin Breast Cancer. 2024 Feb 1:S1526-8209(24)00035.
    PubMed     Abstract available


    January 2024
  37. YOU YH, Kim MK, Lee JY
    Prognosis and Adjusting Factors in Elderly Patients With Triple-Negative Breast Cancer: Comparing With Young and Middle Age Groups.
    Clin Breast Cancer. 2024 Jan 30:S1526-8209(24)00027.
    PubMed     Abstract available


  38. MOKBEL K
    Elucidating Axillary Soft Tissue Involvement in Breast Cancer: Unveiling Metastatic Mechanisms and Therapeutic Perspectives.
    Clin Breast Cancer. 2024 Jan 29:S1526-8209(24)00024.
    PubMed     Abstract available


  39. ZHU Z, Wang H, Qian X, Xue M, et al
    Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK/STAT3 Signaling.
    Clin Breast Cancer. 2024 Jan 26:S1526-8209(24)00025.
    PubMed     Abstract available


  40. KAVISHAHI NN, Rezaee A, Jalalian S
    The Impact of miRNAs on the Efficacy of Tamoxifen in Breast Cancer Treatment: A Systematic Review.
    Clin Breast Cancer. 2024 Jan 26:S1526-8209(24)00026.
    PubMed     Abstract available


  41. LIU D, Chang L, Zhao X, Dai L, et al
    Effect of T Stages on the Choice of Axillary Evaluation Modality in Breast Cancer Patients With 1-2 Sentinel Lymph Node Metastases.
    Clin Breast Cancer. 2024 Jan 24:S1526-8209(24)00022.
    PubMed     Abstract available


  42. MALHOTRA S, Tadros AB
    New Strategies for Locally Advanced Breast Cancer: A Review of Inflammatory Breast Cancer and Nonresponders.
    Clin Breast Cancer. 2024 Jan 21:S1526-8209(24)00009.
    PubMed     Abstract available


  43. KESKINKILIC M, Sacks R
    Antibody-Drug Conjugates in Triple Negative Breast Cancer.
    Clin Breast Cancer. 2024 Jan 20:S1526-8209(24)00008.
    PubMed     Abstract available


  44. HAN J, Hua H, Fei J, Liu J, et al
    Prediction of Disease-Free Survival in Breast Cancer using Deep Learning with Ultrasound and Mammography: A Multicenter Study.
    Clin Breast Cancer. 2024 Jan 17:S1526-8209(24)00006.
    PubMed     Abstract available


  45. KNOWLES AJ
    Advocating for Enhanced Patient Engagement in Breast Cancer Care: Impact of Residual Increased Lateral Adiposity and Consideration of the Pursuit of "Living Flat".
    Clin Breast Cancer. 2024 Jan 17:S1526-8209(24)00003.
    PubMed     Abstract available


  46. PLOUMAKI I, Triantafyllou E, Koumprentziotis IA, Karampinos K, et al
    Cyclin-Dependent Kinase 4/6 Inhibitors as Neoadjuvant Therapy of Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: What do we Know so Far?
    Clin Breast Cancer. 2024 Jan 16:S1526-8209(24)00002.
    PubMed     Abstract available


  47. ROLLIN FG, Lee-Rey S, Wong-Serrano E, Habert S, et al
    The Importance of Naming Structural Racism as a Root Cause of Racial Inequities in Breast Cancer Outcomes.
    Clin Breast Cancer. 2024 Jan 14:S1526-8209(24)00007.
    PubMed    


  48. LO FARO L, Fogliata A, Franceschini D, Spoto R, et al
    Adjuvant Hypofractionated Whole Breast Irradiation (WBI) vs. Accelerated Partial Breast Irradiation (APBI) in Postmenopausal Women with Early Stage Breast Cancer: 5Years Update of the HYPAB Trial.
    Clin Breast Cancer. 2024 Jan 5:S1526-8209(23)00328.
    PubMed     Abstract available


  49. KESKINKILIC M, Gokmen-Polar Y, Badve SS
    Triple Negative Breast Cancers: An Obsolete Entity?
    Clin Breast Cancer. 2024;24:1-6.
    PubMed     Abstract available


  50. ZOCCALI G, Pozzi M, Gullo P, Michelina VV, et al
    Regina Elena Institute (R.E.I.) Protocol for Breast Implant Salvage: Preliminary Results.
    Clin Breast Cancer. 2024;24:65-71.
    PubMed     Abstract available


    December 2023
  51. SUN XY, Wang CQ, Mao Y, Zhang ZQ, et al
    Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer.
    Clin Breast Cancer. 2023 Dec 30:S1526-8209(23)00327.
    PubMed     Abstract available


  52. WICKBERG A, Prag C, Valachis A, Karlsson L, et al
    Intraoperative Radiation Therapy Delivered by Brachytherapy in Breast Cancer: An Interim Analysis of a Phase 2 Trial.
    Clin Breast Cancer. 2023 Dec 26:S1526-8209(23)00310.
    PubMed     Abstract available


  53. WILLIAMS AD, Weiss A
    Recent Advances in the Upfront Surgical Management of the Axilla in Patients with Breast Cancer.
    Clin Breast Cancer. 2023 Dec 22:S1526-8209(23)00311.
    PubMed     Abstract available


  54. NILSSON L, Khazaei S, Tryggvadottir H, Bjorner S, et al
    Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients.
    Clin Breast Cancer. 2023 Dec 21:S1526-8209(23)00306.
    PubMed     Abstract available


  55. MCKECHNIE T, Brown Z, Lovrics O, Yang S, et al
    Concurrent Use of Statins in Patients Undergoing Curative Intent Treatment for Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2023 Dec 16:S1526-8209(23)00305.
    PubMed     Abstract available


  56. GIRARDELLI S, Bonomo B, Papale M, di Loreto E, et al
    Weekly Paclitaxel for Pregnancy Associated Breast Cancer.
    Clin Breast Cancer. 2023 Dec 13:S1526-8209(23)00302.
    PubMed     Abstract available


  57. ZHANG C, Wang J, Wang H, Li J, et al
    Interference of the Circular RNA Sperm Antigen With Calponin Homology and Coiled-Coil Domains 1 Suppresses Growth and Promotes Apoptosis of Breast Cancer Cells Partially Through Targeting miR-1236-3p/Chromobox 8 Pathway.
    Clin Breast Cancer. 2023 Dec 2:S1526-8209(23)00304.
    PubMed     Abstract available


  58. CAZZATO V, Scarabosio A, Bottosso S, Rodda A, et al
    Early Seroma Treatment Protocol Based on US-Guided Aspiration in DTI Prepectoral Reconstruction: A Prospective Study.
    Clin Breast Cancer. 2023;23:e542-e548.
    PubMed     Abstract available


  59. LIU M, Zhou X, Gao L, Wang Z, et al
    Considerable Long-Term Aesthetic Outcomes and Oncologic Safety of Breast-Conserving Surgery Via a Periareolar Incision: A Retrospective Study.
    Clin Breast Cancer. 2023;23:e549-e559.
    PubMed     Abstract available


  60. DE SOUSA CFPM, Pereira AAL, Arruda GV, Gouveia AG, et al
    Real-World Evidence on the Use of Endocrine Therapy for Ductal Carcinoma In Situ in Patients Treated With Breast-Conserving Surgery Followed by Postoperative Radiation Therapy: A Brazilian Retrospective Cohort Study.
    Clin Breast Cancer. 2023;23:e499-e506.
    PubMed     Abstract available


  61. SCARABOSIO A, Contessi Negrini F, Pisano G, Beorchia Y, et al
    Prepectoral Direct-To-Implant One-Stage Reconstruction With ADMs: Safety and Outcome in "Thin Patients".
    Clin Breast Cancer. 2023;23:e507-e514.
    PubMed     Abstract available


  62. DEPRETTO C, Della Pepa G, De Berardinis C, Suman L, et al
    Magnetic Localization of Breast Lesions: A Large-Scale European Evaluation in a National Cancer Institute.
    Clin Breast Cancer. 2023;23:e491-e498.
    PubMed     Abstract available


    November 2023
  63. KOJUNDZIC I, Chehade R, Gonzalez CAC, Fritz J, et al
    Brain Metastases in the Setting of Stable Versus Progressing Extracranial Disease Among Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2023 Nov 25:S1526-8209(23)00303.
    PubMed     Abstract available


  64. GABA AG, Cao L, Renfrew RJ, Witte D, et al
    The Impact of Medicaid Expansion Under the Affordable Care Act on the Gap Between American Indians and Whites in Breast Cancer Management and Prognosis.
    Clin Breast Cancer. 2023 Nov 24:S1526-8209(23)00301.
    PubMed     Abstract available


  65. LI X, Zhang J, Zhang G, Liu J, et al
    Contrast-Enhanced Ultrasound and Conventional Ultrasound Characteristics of Breast Cancer With Different Molecular Subtypes.
    Clin Breast Cancer. 2023 Nov 20:S1526-8209(23)00289.
    PubMed     Abstract available


  66. GIRIDHAR P, Pradhan S, Pujari L, Singh P, et al
    Is FAST FORWARD the Way Forward in Radiotherapy for Locally Advanced Breast Cancer - Learnings From the COVID Pandemic.
    Clin Breast Cancer. 2023 Nov 19:S1526-8209(23)00287.
    PubMed     Abstract available


  67. HSIEH CT, Lee WC, Chiang CJ, Wang CC, et al
    The Risk of Cancer-Associated and Radiotherapy-Associated Cardiovascular Diseases among Patients with Breast Cancer.
    Clin Breast Cancer. 2023 Nov 17:S1526-8209(23)00286.
    PubMed     Abstract available


  68. YANG H, Sun Y, Wang P, Qiao J, et al
    The Impact of Sentinel Lymph Node Biopsy on Female Patients With T3-4c Breast Cancer and 1-2 Positive Lymph Nodes: A Population-Based Cohort Study.
    Clin Breast Cancer. 2023 Nov 17:S1526-8209(23)00288.
    PubMed     Abstract available


  69. KURT B, Kapucu S, Cakmak Oksuzoglu BO
    Effects of Oral Cryotherapy on Anticipatory, and Acute Nausea and Vomiting in Patients With Breast Cancer Undergoing Adjuvant Chemotherapy: A Randomized Controlled Clinical Trial.
    Clin Breast Cancer. 2023 Nov 3:S1526-8209(23)00272.
    PubMed     Abstract available


  70. IBRAGIMOVA KIE, Geurts SME, Laczko D, Meegdes M, et al
    Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry.
    Clin Breast Cancer. 2023 Nov 2:S1526-8209(23)00269.
    PubMed     Abstract available


  71. FERNANDEZ G, Zeineh J, Prastawa M, Scott R, et al
    Analytical Validation of the PreciseDx Digital Prognostic Breast Cancer Test in Early-Stage Breast Cancer.
    Clin Breast Cancer. 2023 Nov 2:S1526-8209(23)00268.
    PubMed     Abstract available


  72. KIM HJ, Choi WJ, Cha JH, Shin HJ, et al
    Prediction of the MammaPrint Risk Group Using MRI Features in Women With Estrogen Receptor-Positive, HER2-Negative, and 1 to 3 Node-Positive Invasive Breast Cancer.
    Clin Breast Cancer. 2023 Nov 2:S1526-8209(23)00270.
    PubMed     Abstract available


    October 2023
  73. HALIMA A, Parker S, Fane L, Sayed S, et al
    Five Fraction Accelerated Partial Breast Irradiation Versus Intraoperative Radiation Therapy for Early-Stage Breast Cancer.
    Clin Breast Cancer. 2023 Oct 30:S1526-8209(23)00261.
    PubMed     Abstract available


  74. MELSON JW, Koethe B, Mohanty S, Babroudi S, et al
    Atherosclerotic Cardiovascular Disease Risk and Longitudinal Risk Factor Management Among Patients With Breast Cancer.
    Clin Breast Cancer. 2023 Oct 26:S1526-8209(23)00266.
    PubMed     Abstract available


  75. WU P, Wu SG, He ZY
    Nomogram Update to Predict the High Genomic Risk Breast Cancer by Different Races.
    Clin Breast Cancer. 2023 Oct 22:S1526-8209(23)00265.
    PubMed     Abstract available


  76. WANG J, Di W, Shi K, Wang S, et al
    Axilla View of Mammography in Preoperative Axillary Lymph Node Evaluation of Breast Cancer Patients: A Pilot Study.
    Clin Breast Cancer. 2023 Oct 17:S1526-8209(23)00264.
    PubMed     Abstract available


  77. WOOLDRIK S, van de Voort EMF, Struik GM, Birnie E, et al
    The Effect of Intraoperative Margin Assessment During Breast Conserving Surgery for Breast Cancer in a Dutch Cohort.
    Clin Breast Cancer. 2023 Oct 12:S1526-8209(23)00262.
    PubMed     Abstract available


  78. ZHANG S, Bai X, Li F, Ni C, et al
    UTP23 Functions in Breast Cancer Progression and Predicts Poor Prognosis of Luminal a Breast Cancer.
    Clin Breast Cancer. 2023 Oct 4:S1526-8209(23)00260.
    PubMed     Abstract available


  79. LIN X, Huo J, Su H, Xu Y, et al
    The Association of Melanoma-Associated Antigen-C Gene With Clinicopathological Characteristics and Prognosis in Breast Cancer: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2023 Oct 4:S1526-8209(23)00258.
    PubMed     Abstract available


  80. HE Y, Zhou J, Liu X, Wei Y, et al
    Evaluation of Association Between Menstrual Cycle Timing and Quantitative Background Parenchymal Enhancement on Breast MRI in Premenopausal Women.
    Clin Breast Cancer. 2023;23:e451-e457.
    PubMed     Abstract available


  81. DENG XY, Cao PW, Nan SM, Pan YP, et al
    Differentiation Between Phyllodes Tumors and Fibroadenomas of Breast Using Mammography-based Machine Learning Methods: A Preliminary Study.
    Clin Breast Cancer. 2023;23:729-736.
    PubMed     Abstract available


  82. POLOTTO S, Pedrazzi G, Bergamini M, D'Abbiero N, et al
    ADM-Assisted Direct-to-Implant Prepectoral Breast Reconstruction in Postmastectomy Radiation Therapy Setting: Long-Term Results.
    Clin Breast Cancer. 2023;23:704-711.
    PubMed     Abstract available


  83. YAN M, Peng C, He D, Xu D, et al
    A Nomogram for Enhancing the Diagnostic Effectiveness of Solid Breast BI-RADS 3-5 Masses to Determine Malignancy Based on Imaging Aspects of Conventional Ultrasonography and Contrast-Enhanced Ultrasound.
    Clin Breast Cancer. 2023;23:693-703.
    PubMed     Abstract available


  84. JAHAN N, Cathcart-Rake E, Vierkant RA, Larson N, et al
    Sexual Dysfunction in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2023 Oct 1:S1526-8209(23)00259.
    PubMed     Abstract available


    September 2023
  85. KHANNA R, Shah E
    Robotics in Screening, Diagnosis and Treatment of Breast Cancer: A Perspective View.
    Clin Breast Cancer. 2023 Sep 29:S1526-8209(23)00257.
    PubMed     Abstract available


  86. MIRIMOGHADDAM MM, Majidpour J, Pashaei F, Arabalibeik H, et al
    HER2GAN: Overcome the Scarcity of HER2 Breast Cancer Dataset Based on Transfer Learning and GAN Model.
    Clin Breast Cancer. 2023 Sep 29:S1526-8209(23)00254.
    PubMed     Abstract available


  87. HASSANZADEH MAKOUI M, Mobini M, Fekri S, Geranpayeh L, et al
    Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With Breast Cancer.
    Clin Breast Cancer. 2023 Sep 26:S1526-8209(23)00255.
    PubMed     Abstract available


  88. GHUMAN N, Ambinder EB, Oluyemi ET, Sutton E, et al
    Clinical and Imaging Features of MRI Screen-Detected Breast Cancer.
    Clin Breast Cancer. 2023 Sep 22:S1526-8209(23)00253.
    PubMed     Abstract available


  89. ZHONG X, Chen P, He P, Wu Y, et al
    Cost-Effectiveness Analysis of Adjuvant Endocrine Therapy With Ovarian Suppression in Premenopausal Patients With Hormone Receptor-Positive Early Breast Cancer in China.
    Clin Breast Cancer. 2023 Sep 19:S1526-8209(23)00237.
    PubMed     Abstract available


  90. IWAMOTO T, Kajiwara Y, Kawada K, Takabatake D, et al
    Long-Term Physical Activity and Body Composition After Exercise and Educational Programs for Breast Cancer: A Randomized Controlled Trial From the Setouchi Breast Project-10.
    Clin Breast Cancer. 2023 Sep 17:S1526-8209(23)00235.
    PubMed     Abstract available


  91. XIAO J, Wang T, Yi J, Huang M, et al
    Neoadjuvant Chemotherapy of Taxanes With or Without Anthracyclines in Different Molecular Subtypes of Breast Cancer: A Propensity Score Matching Study.
    Clin Breast Cancer. 2023 Sep 14:S1526-8209(23)00236.
    PubMed     Abstract available


  92. ZHAO J, Xiao C
    Oncologic Safety of One-Stage Implant-Based Breast Reconstruction in Breast Cancer Patients With Positive Sentinel Lymph Nodes: A Single-Center Retrospective Study Using Propensity Score Matching.
    Clin Breast Cancer. 2023 Sep 13:S1526-8209(23)00233.
    PubMed     Abstract available


  93. ABUJARADEH H, Mazanec SR, Sereika SM, Connolly MC, et al
    Economic Hardship and Associated Factors of Women With Early-Stage Breast Cancer Prior to Chemotherapy Initiation.
    Clin Breast Cancer. 2023 Sep 13:S1526-8209(23)00234.
    PubMed     Abstract available


  94. WANG C, Guo M, Huang L, Sun S, et al
    Factors Influencing Recurrence in Medial Breast Cancer Tumors After Skin Sparing Mastectomy and Immediate Breast Reconstruction.
    Clin Breast Cancer. 2023 Sep 12:S1526-8209(23)00232.
    PubMed     Abstract available


  95. DOWLING GP, Daly GR, Keelan S, Boland F, et al
    Efficacy and Safety of Trastuzumab Deruxtecan in Breast Cancer: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2023 Sep 11:S1526-8209(23)00231.
    PubMed     Abstract available


  96. TANG W, Shao M, Fang W, Wang J, et al
    A Population-Based Research Utilized a Risk Stratification Model to Forecast the Overall Survival of Young Women With Diagnosed Stage IV Breast Cancer.
    Clin Breast Cancer. 2023 Sep 9:S1526-8209(23)00217.
    PubMed     Abstract available


  97. D'ONOFRIO R, Sperduti I, Piacentini F, Barbolini M, et al
    Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis.
    Clin Breast Cancer. 2023 Sep 9:S1526-8209(23)00218.
    PubMed     Abstract available


  98. MATTAR A, Hegg R, Tayar DO, Rocha M, et al
    Prognostic Factors and Survival Outcomes of Patients With Early HER2+ Breast Cancer Treated With Trastuzumab in a Brazilian Public Reference Center: A Real-World Study.
    Clin Breast Cancer. 2023 Sep 7:S1526-8209(23)00216.
    PubMed     Abstract available


    August 2023
  99. JAYAN A, Raghavendra AS, Bassett R, Barcenas CH, et al
    Bone-Targeted Therapy Regimen and Skeletal-Related Events in Patients Surviving Longer Than 2 Years With Metastatic Breast Cancer and Bone Metastasis.
    Clin Breast Cancer. 2023 Aug 29:S1526-8209(23)00215.
    PubMed     Abstract available


  100. JONES KD, Lakatta AC, Haddock NT, Teotia SS, et al
    The Effects of High Deductible Health Plans on Breast Cancer Treatment and Reconstruction.
    Clin Breast Cancer. 2023 Aug 25:S1526-8209(23)00213.
    PubMed     Abstract available


  101. COMINI ACM, Carvalho BM, Moreira MJB, Reis PCA, et al
    Safety and Serum Estradiol Levels in Hormonal Treatments for Vulvovaginal Atrophy in Breast Cancer Survivors: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2023 Aug 22:S1526-8209(23)00210.
    PubMed     Abstract available


  102. BRAVO-SOLARTE DC, Zhang F, Anampa JD
    Assessment of Use and Impact of Chemotherapy in Lymph Node-Negative, T1a Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2023 Aug 8:S1526-8209(23)00209.
    PubMed     Abstract available


  103. KNELSON LP, Rosenberg S, Snow C, Rigby K, et al
    Survivorship Navigation for Young Women With Early-Stage Breast Cancer.
    Clin Breast Cancer. 2023 Aug 8:S1526-8209(23)00205.
    PubMed     Abstract available


  104. ALDRICH J, Canning M, Bhave M
    Monitoring of Triple Negative Breast Cancer After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2023 Aug 5:S1526-8209(23)00208.
    PubMed     Abstract available


  105. BANSAL R, Van Swearingen AED, Anders CK
    Triple Negative Breast Cancer and Brain Metastases.
    Clin Breast Cancer. 2023 Aug 4:S1526-8209(23)00204.
    PubMed     Abstract available


  106. HUANG H, Wei T, Zhang A, Zhang H, et al
    Comparison of Survival Outcomes in Young Patients With Breast Cancer Receiving Contralateral Prophylactic Mastectomy Versus Unilateral Mastectomy.
    Clin Breast Cancer. 2023 Aug 3:S1526-8209(23)00206.
    PubMed     Abstract available


  107. MANSOORI B, Kiani S, Mezajin AA, Zandi P, et al
    MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2.
    Clin Breast Cancer. 2023 Aug 3:S1526-8209(23)00207.
    PubMed     Abstract available


  108. BACOS JT, Doren E, D'Souza A, Jorns J, et al
    Surgical Management of Breast Amyloidosis.
    Clin Breast Cancer. 2023;23:e359-e367.
    PubMed     Abstract available


  109. WANG O, Zhang W, Chen S, Cao F, et al
    A Multicenter, Randomized, Controlled Study of the Breast Biopsy and Circumferential Excision System for Breast Lesions.
    Clin Breast Cancer. 2023;23:640-648.
    PubMed     Abstract available


  110. GARCIA-CALVO L, Marti Alvarez C, Gutierrez AH, Garcia AB, et al
    Sentinel Node Biopsy in Patients With Breast Carcinoma Without Axillary Involvement at Diagnosis Receiving Primary Systemic Therapy.
    Clin Breast Cancer. 2023;23:672-679.
    PubMed     Abstract available


  111. HAN LK, Hussain A, Dodelzon K, Ginter PS, et al
    Active Surveillance of Atypical Ductal Hyperplasia of the Breast.
    Clin Breast Cancer. 2023;23:649-657.
    PubMed     Abstract available


  112. FERNANDES I, Scorsato A, Kaliks R, Corpa M, et al
    Tumor-Infiltrating Lymphocytes in HER2-Low Breast Cancer.
    Clin Breast Cancer. 2023 Aug 1:S1526-8209(23)00203.
    PubMed     Abstract available


    July 2023
  113. GARUTTI M, Cucciniello L, Arpino G, Fabi A, et al
    Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus Paper.
    Clin Breast Cancer. 2023 Jul 26:S1526-8209(23)00202.
    PubMed     Abstract available


  114. DING W, Ye D, Zhu H, Lin Y, et al
    Survival Benefit of Adjuvant Chemotherapy in Node-Positive Breast Cancer With a 21-Gene Recurrence Score of 14 to 25: A Real-World Study Based on the Inverse Probability of Treatment Weighting Method.
    Clin Breast Cancer. 2023 Jul 15:S1526-8209(23)00190.
    PubMed     Abstract available


  115. VALCARCEL B, Torres-Roman JS, Enriquez D, Vidaurre T, et al
    Temporal Variation of Treatment Patterns and Survival Outcomes of Triple-Negative Breast Cancer Patients: A Real-World Experience From 2000 to 2014.
    Clin Breast Cancer. 2023 Jul 13:S1526-8209(23)00189.
    PubMed     Abstract available


  116. D'ONOFRIO R, Omarini C, Toss A, Sperduti I, et al
    Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting.
    Clin Breast Cancer. 2023 Jul 7:S1526-8209(23)00170.
    PubMed     Abstract available


  117. LIM ST, Choi HS, Kim K, Hahn S, et al
    Hounsfield Units Predict Survival of Patients With Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Negative Breast Cancer.
    Clin Breast Cancer. 2023 Jul 5:S1526-8209(23)00169.
    PubMed     Abstract available


  118. JACOB S, Johnson M, Roque B, Quintal L, et al
    Crofelemer for the Management of Neratinib-Associated Diarrhea in Patients With HER2+ Early-Stage Breast Cancer.
    Clin Breast Cancer. 2023 Jul 4:S1526-8209(23)00171.
    PubMed     Abstract available


  119. CONROY M, Kamaraju S, Powell M, Harris A, et al
    Racial and Ethnic Differences in the Use of Electronic Medical Record Messaging Among Patients With Breast Cancer: A Quality Improvement Study.
    Clin Breast Cancer. 2023 Jul 4:S1526-8209(23)00172.
    PubMed     Abstract available


    June 2023
  120. NAIR NS, Das A, Shet T, Kirti K, et al
    Accuracy of Intraoperative Frozen Section Analysis of Lymph Nodes in Women Undergoing Axillary Sampling for Treatment of Breast Cancer: Single Institution Audit.
    Clin Breast Cancer. 2023 Jun 28:S1526-8209(23)00167.
    PubMed     Abstract available


  121. SCHAAB M, Wijlens KAE, Bode C
    Psychological Coping Factors Associated With Breast Cancer-Related Fatigue: A Systematic Review of Recent Evidence for Stages 0 to III.
    Clin Breast Cancer. 2023 Jun 25:S1526-8209(23)00162.
    PubMed     Abstract available


  122. CORREDOR G, Bharadwaj S, Pathak T, Viswanathan VS, et al
    A Review of AI-Based Radiomics and Computational Pathology Approaches in Triple-Negative Breast Cancer: Current Applications and Perspectives.
    Clin Breast Cancer. 2023 Jun 21:S1526-8209(23)00161.
    PubMed     Abstract available


  123. MEDFORD AJ, Denault EN, Moy B, Parsons HA, et al
    Circulating Tumor DNA in Breast Cancer: Current and Future Applications.
    Clin Breast Cancer. 2023 Jun 20:S1526-8209(23)00165.
    PubMed     Abstract available


  124. PIVOT X, Spano JP, Espie M, Jouannaud C, et al
    Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer.
    Clin Breast Cancer. 2023 Jun 20:S1526-8209(23)00164.
    PubMed     Abstract available


  125. TOUATI R, Pauly L, Reyal F, Kirova Y, et al
    Breast Cancer and Mediastinal Hodgkin's Lymphomas: Multidisciplinary Discussion.
    Clin Breast Cancer. 2023 Jun 20:S1526-8209(23)00163.
    PubMed     Abstract available


  126. SHARIFI MN, O'Regan RM, Wisinski KB
    Is the Androgen Receptor a Viable Target in Triple Negative Breast Cancer in 5 Years?
    Clin Breast Cancer. 2023 Jun 20:S1526-8209(23)00166.
    PubMed     Abstract available


  127. MANOCHA A, Brockton NT, Cook L, Kopciuk KA, et al
    Low Serum Vitamin D Associated With Increased Tumor Size and Higher Grade in Premenopausal Canadian Women With Breast Cancer.
    Clin Breast Cancer. 2023 Jun 14:S1526-8209(23)00155.
    PubMed     Abstract available


  128. SHEKHAR N, Jaiswal R, Joseph L, Jain S, et al
    An Overview of Psychological Analysis of Breast Cancer Patients undergoing Modified Radical Mastectomy and Breast Conservation Surgery and its impact on Objectified Body Consciousness at a Tertiary Care Cancer Centre in South India.
    Clin Breast Cancer. 2023 Jun 7:S1526-8209(23)00139.
    PubMed     Abstract available


  129. CAZIUC A, Fagarasan V, Fagarasan G, Dindelegan GC, et al
    Adverse Outcome of Two-Staged Breast Reconstruction: More Than One Culprit.
    Clin Breast Cancer. 2023;23:e267-e272.
    PubMed     Abstract available


  130. FLEEGE NMG, Li Y, Kidwell KM, Henry NL, et al
    Ovarian Function Suppression in Premenopausal Women With Concurrent Endocrine Therapy Use.
    Clin Breast Cancer. 2023;23:454-460.
    PubMed     Abstract available


  131. STANKOWSKI TJ, Alagoz E, Jacobson N, Neuman HB, et al
    Factors Associated With Socioeconomic Disparities in Breast Reconstruction: Perspectives of Wisconsin Surgeons.
    Clin Breast Cancer. 2023;23:461-467.
    PubMed     Abstract available


  132. FENCER MG, Krupa KA, Bleich GC, Grumet S, et al
    Diagnosis, Management, and Surveillance for Patients With PALB2, CHEK2, and ATM Gene Mutations.
    Clin Breast Cancer. 2023;23:e194-e199.
    PubMed     Abstract available


  133. BISQUERA OC JR, Valparaiso AP, Espiritu NT, Ayuste EC Jr, et al
    Diagnostic Validity of Point-of-Care Breast Ultrasound for Females with Palpable Breast Masses.
    Clin Breast Cancer. 2023;23:e189-e193.
    PubMed     Abstract available


  134. KWONG A, Co M, Fukuma E
    Prospective Clinical Trial on Expanding Indications for Cryosurgery for Early Breast Cancers.
    Clin Breast Cancer. 2023;23:363-368.
    PubMed     Abstract available


    May 2023
  135. YANG J, Zhang S, Jiang W
    Impact of Beta Blockers on Breast Cancer Incidence and Prognosis.
    Clin Breast Cancer. 2023 May 31:S1526-8209(23)00136.
    PubMed     Abstract available


  136. MAI N, Abuhadra N, Jhaveri K
    Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future Directions.
    Clin Breast Cancer. 2023 May 28:S1526-8209(23)00133.
    PubMed     Abstract available


  137. WANG X, Hua H, Han J, Zhong X, et al
    Evaluation of Multiparametric MRI Radiomics-Based Nomogram in Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Two-Center study.
    Clin Breast Cancer. 2023 May 27:S1526-8209(23)00134.
    PubMed     Abstract available


  138. VANNI G, Pellicciaro M, Materazzo M, Buonomo OC, et al
    Axillary Reverse Mapping in Breast Cancer: Would We Need it in the Era of Surgical De-Escalation?
    Clin Breast Cancer. 2023 May 27:S1526-8209(23)00138.
    PubMed    


  139. ERGUN Y, Akagunduz B, Karacin C, Turker S, et al
    The Effect of HER2-Low Status on Pathological Complete Response and Survival in Triple-Negative Breast Cancer: A Systemic Review and Meta-Analysis.
    Clin Breast Cancer. 2023 May 25:S1526-8209(23)00137.
    PubMed     Abstract available


  140. HUSSAIN MM, Ashley G, Daniel S, Sachin J, et al
    Implementation of a Multidisciplinary Inflammatory Breast Cancer Program for Quality Improvement.
    Clin Breast Cancer. 2023 May 24:S1526-8209(23)00135.
    PubMed     Abstract available


  141. SCHIEBER T, Steele S, Collins S, Berger M, et al
    Effect of Concurrent Proton Pump Inhibitors With Palbociclib Tablets for Metastatic Breast Cancer.
    Clin Breast Cancer. 2023 May 24:S1526-8209(23)00131.
    PubMed     Abstract available


  142. TZSCHASCHEL M, Friedl TWP, Schochter F, Schutze S, et al
    Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients.
    Clin Breast Cancer. 2023 May 23:S1526-8209(23)00132.
    PubMed     Abstract available


  143. ZHU S, Zheng Z, Hu W, Lei C, et al
    Conditional Cancer-Specific Survival for Inflammatory Breast Cancer: Analysis of SEER, 2010 to 2016.
    Clin Breast Cancer. 2023 May 19:S1526-8209(23)00110.
    PubMed     Abstract available


  144. GABRIELOVA L, Selingerova I, Zatecky J, Zapletal O, et al
    Comparison of 3 Different Systems for Non-wire Localization of Lesions in Breast Cancer Surgery.
    Clin Breast Cancer. 2023 May 18:S1526-8209(23)00111.
    PubMed     Abstract available


  145. LAKKAD M, Martin B, Li C, Harrington S, et al
    Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors.
    Clin Breast Cancer. 2023 May 18:S1526-8209(23)00107.
    PubMed     Abstract available


  146. CHEN J, Zhou Y, Wu M, Yuan Y, et al
    m6A Modification Mediates Exosomal LINC00657 to Trigger Breast Cancer Progression Via Inducing Macrophage M2 Polarization.
    Clin Breast Cancer. 2023 May 15:S1526-8209(23)00092.
    PubMed     Abstract available


  147. PENG Y, Huang X, Wang H
    Serum lncRNA LINC01535 as Biomarker of Diagnosis, Prognosis, and Disease Progression in Breast Cancer.
    Clin Breast Cancer. 2023 May 14:S1526-8209(23)00109.
    PubMed     Abstract available


  148. GRAFF SL, Yan F, Abdou Y
    Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer.
    Clin Breast Cancer. 2023 May 13:S1526-8209(23)00108.
    PubMed     Abstract available


  149. CAPARICA R, Richard F, Brandao M, Awada A, et al
    Corrigendum to "Prognostic and predictive impact of beta-2 adrenergic receptor expression in HER2-positive breast cancer" [Clin Breast Cancer 2020; 20:262-73.e7].
    Clin Breast Cancer. 2023 May 12:S1526-8209(23)00081.
    PubMed    


  150. NGUYEN RH, Silva Y, Lu J, Chen Z, et al
    Race and Ethnicity Reporting and Enrollment Disparities in Clinical Trials Leading to FDA Approvals for Breast Cancer Between 2010 and 2020.
    Clin Breast Cancer. 2023 May 10:S1526-8209(23)00096.
    PubMed     Abstract available


  151. ZHANG XW, Ge YZ, Song MM, Ruan GT, et al
    Prognostic Power of Nutrition-Inflammation Indicators in Patients With Breast Cancer.
    Clin Breast Cancer. 2023 May 5:S1526-8209(23)00095.
    PubMed     Abstract available


  152. TSAI YL, Chuang YC, Chen CP, Lee YC, et al
    Feasibility of Aerobic Exercise Training to Mitigate Cardiotoxicity of Breast Cancer Therapy: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2023 May 3:S1526-8209(23)00094.
    PubMed     Abstract available


    April 2023
  153. CHERVU N, Darbinian K, Sakowitz S, Verma A, et al
    Disparate Utilization of Breast Conservation Therapy in the Surgical Management of Early-Stage Breast Cancer.
    Clin Breast Cancer. 2023 Apr 25:S1526-8209(23)00093.
    PubMed     Abstract available


  154. BRUGIONI E, Cathcart-Rake E, Metsker J, Gustafson E, et al
    Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer: Overcoming Challenges in Genetic Testing and Clinical Considerations When Using Talazoparib.
    Clin Breast Cancer. 2023 Apr 23:S1526-8209(23)00091.
    PubMed     Abstract available


  155. NAJIB B, Gosset M, Abdallah W, Haudebourg J, et al
    SENODAY: A New Perspective of Handling Breast Cancer.
    Clin Breast Cancer. 2023 Apr 22:S1526-8209(23)00090.
    PubMed     Abstract available


  156. LOBIG F, Caleyachetty A, Forrester L, Morris E, et al
    Performance of Supplemental Imaging Modalities for Breast Cancer in Women With Dense Breasts: Findings From an Umbrella Review and Primary Studies Analysis.
    Clin Breast Cancer. 2023 Apr 19:S1526-8209(23)00088.
    PubMed     Abstract available


  157. THOMAS A, Douglas E, Reis-Filho JS, Gurcan MN, et al
    Metaplastic Breast Cancer: Current Understanding and Future Directions.
    Clin Breast Cancer. 2023 Apr 19:S1526-8209(23)00089.
    PubMed     Abstract available


  158. LI X, Yang L, Jiao X
    Development and Validation of a Nomogram for Predicting Axillary Lymph Node Metastasis in Breast Cancer.
    Clin Breast Cancer. 2023 Apr 12:S1526-8209(23)00087.
    PubMed     Abstract available


  159. DA COSTA VIEIRA RA, Sant'Anna D, Laus AC, Bacchi CE, et al
    Genetic Ancestry of 1127 Brazilian Breast Cancer Patients and Its Correlation With Molecular Subtype and Geographic Region.
    Clin Breast Cancer. 2023 Apr 12:S1526-8209(23)00086.
    PubMed     Abstract available


  160. JORGENSEN MG, Gozeri E, Petersen TG, Sorensen JA, et al
    Surgical-Site Infection is Associated With Increased Risk of Breast Cancer-Related Lymphedema: A Nationwide Cohort Study.
    Clin Breast Cancer. 2023 Apr 5:S1526-8209(23)00085.
    PubMed     Abstract available


  161. KHOSRAVI S, Khayyamfar A, Karimi J, Tutuni M, et al
    Machine Learning Approach for the Determination of the Best Cut-Off Points for Ki67 Proliferation Index in Adjuvant and Neo-Adjuvant Therapy Breast Cancer Patients.
    Clin Breast Cancer. 2023 Apr 3:S1526-8209(23)00084.
    PubMed     Abstract available


  162. WONG DJ, Gandomkar Z, Lewis S, Reed W, et al
    Do Reader Characteristics Affect Diagnostic Efficacy in Screening Mammography? A Systematic Review.
    Clin Breast Cancer. 2023;23:e56-e67.
    PubMed     Abstract available


  163. SHAH C, Fleming-Hall E, Asha W
    Update on Accelerated Whole Breast Irradiation.
    Clin Breast Cancer. 2023;23:237-240.
    PubMed     Abstract available


  164. PAGLIARA D, Schiavone L, Garganese G, Bove S, et al
    Predicting Mastectomy Skin Flap Necrosis: A Systematic Review of Preoperative and Intraoperative Assessment Techniques.
    Clin Breast Cancer. 2023;23:249-254.
    PubMed     Abstract available


  165. STOCCO C, Cazzato V, Renzi N, Manara M, et al
    Central Mound Technique in Oncoplastic Surgery: A Valuable Technique to Save Your Bacon.
    Clin Breast Cancer. 2023;23:e77-e84.
    PubMed     Abstract available


  166. LORETI A, Fanelli B, Abate O, Spallone D, et al
    Surgical Delay of Nipple Areola Complex: A Powerful Technique to Extend the Indication of Nipple-Sparing Mastectomy.
    Clin Breast Cancer. 2023;23:255-264.
    PubMed     Abstract available


  167. OLERU OO, Akhavan AA, Seyidova N, Ibelli T, et al
    Did the National Ban on Bacitracin Irrigation Affect Infection Rates in Implant-Based Breast Reconstruction? An Analysis of a National Database.
    Clin Breast Cancer. 2023;23:e103-e108.
    PubMed     Abstract available


  168. WANG Y, Tang L, Chen P, Chen M, et al
    The Role of a Deep Learning-Based Computer-Aided Diagnosis System and Elastography in Reducing Unnecessary Breast Lesion Biopsies.
    Clin Breast Cancer. 2023;23:e112-e121.
    PubMed     Abstract available


  169. BARNI S, Fabi A, Petrelli F
    Lobular Carcinoma of the Breast and Utility of Oncotype Dx(R): a Retrospective Decision Impact Analysis.
    Clin Breast Cancer. 2023;23:e173-e174.
    PubMed     Abstract available


    March 2023
  170. HUANG X, Lin D, Lin S, Luo S, et al
    Cost-effectiveness and Value-based Pricing of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Low HER2 Expression.
    Clin Breast Cancer. 2023 Mar 31:S1526-8209(23)00082.
    PubMed     Abstract available


  171. COOK P, Yin G, Ayeni FE, Eslick GD, et al
    Does Immediate Breast Reconstruction Lead to a Delay in Adjuvant Chemotherapy for Breast Cancer? A Meta-Analysis and Systematic Review.
    Clin Breast Cancer. 2023 Mar 31:S1526-8209(23)00083.
    PubMed     Abstract available


  172. LOMMA C, Chih H, Chan A
    Adjuvant Dose Dense Chemotherapy in Patients With Obesity: Short-Term Toxicities and Breast Cancer Outcome.
    Clin Breast Cancer. 2023 Mar 31:S1526-8209(23)00077.
    PubMed     Abstract available


  173. DAVEY MG, Kerin EP, McLaughlin RP, Barry MK, et al
    Evaluating the Necessity for Routine Sentinel Lymph Node Biopsy in Postmenopausal Patients Being Treated for Clinically Node Negative Breast Cancer the Era of RxPONDER.
    Clin Breast Cancer. 2023 Mar 30:S1526-8209(23)00080.
    PubMed     Abstract available


  174. WILLERS N, Neven P, Floris G, Colpaert C, et al
    The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study.
    Clin Breast Cancer. 2023 Mar 22:S1526-8209(23)00075.
    PubMed     Abstract available


  175. O'SHAUGHNESSY J, Gradishar W, O'Regan R, Gadi V, et al
    Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics.
    Clin Breast Cancer. 2023 Mar 22:S1526-8209(23)00076.
    PubMed     Abstract available


  176. ESTEBSARI F, Rahimi Khalifehkandi Z, Latifi M, Farhadinasab A, et al
    Protection Motivation Theory and Prevention of Breast Cancer: A Systematic Review.
    Clin Breast Cancer. 2023 Mar 14:S1526-8209(23)00043.
    PubMed     Abstract available


  177. MAZZEGA-FABBRO C, Polesel J, Spazzapan S, Meneghetti L, et al
    Mild Cryotherapy for Prevention of Paclitaxel-Induced Nail Toxicity in Breast Cancer Patients: A Phase II Single-Arm Clinical Trial.
    Clin Breast Cancer. 2023 Mar 8:S1526-8209(23)00057.
    PubMed     Abstract available


  178. LIU J, Chen J, Sun J, Yao L, et al
    Low Expression of PALB2 is Associated With Poor Survival in Chinese Women With Primary Breast Cancer.
    Clin Breast Cancer. 2023 Mar 8:S1526-8209(23)00055.
    PubMed     Abstract available


  179. BO J, Yu B, Bi R, Xu X, et al
    Conversion of ER and HER2 Status After Neoadjuvant Therapy in Chinese Breast Cancer Patients.
    Clin Breast Cancer. 2023 Mar 8:S1526-8209(23)00056.
    PubMed     Abstract available


  180. MIN J, Yeon S, Ryu J, Kim JY, et al
    Shoulder Function and Health Outcomes in Newly Diagnosed Breast Cancer Patients Receiving Surgery: A Prospective Study.
    Clin Breast Cancer. 2023 Mar 6:S1526-8209(23)00044.
    PubMed     Abstract available


  181. SUN Y, Zhu C, Xu F, Cui S, et al
    Circulating Tumor DNA as a Novel Biomarker Optimizing Treatment for Triple Negative Breast Cancer.
    Clin Breast Cancer. 2023 Mar 2:S1526-8209(23)00042.
    PubMed     Abstract available


    February 2023
  182. CHAI BS, Ingledew PA
    Characteristics Assessment of Online YouTube Videos on Radiotherapy for Breast Cancer.
    Clin Breast Cancer. 2023 Feb 24:S1526-8209(23)00041.
    PubMed     Abstract available


  183. ROSKAM JS, Uretsky M, Fornari M, Chappuis CA, et al
    The Effects of the COVID-19 Pandemic on Mastectomy Outcomes for Breast Cancer.
    Clin Breast Cancer. 2023 Feb 24:S1526-8209(23)00040.
    PubMed     Abstract available


  184. PAN J, Peng L, Xia C, Wang A, et al
    Survival Nomogram for Patients With Locally Advanced Breast Cancer Undergoing Immediate Breast Reconstruction: A SEER Population-Based Study.
    Clin Breast Cancer. 2023 Feb 21:S1526-8209(23)00038.
    PubMed     Abstract available


  185. WANG X, Wang J, He Y, Li J, et al
    Observation Effectiveness of Dose-Dense Neoadjuvant Anthracycline Sequential Weekly Paclitaxel for Triple-Negative Breast Cancer Patients.
    Clin Breast Cancer. 2023 Feb 21:S1526-8209(23)00039.
    PubMed     Abstract available


  186. WANG L, Zhao L, Zhang Y, Shao S, et al
    Comprehensive Analysis of the Expression and Prognosis of chromobox Family Members in Breast Cancer.
    Clin Breast Cancer. 2023 Feb 15:S1526-8209(23)00036.
    PubMed     Abstract available


  187. YAN K, Gao Y, Heller SL
    Breast Cancer Screening Utilization and Outcomes in Women With Neurofibromatosis Type 1.
    Clin Breast Cancer. 2023 Feb 12:S1526-8209(23)00035.
    PubMed     Abstract available


  188. WANG M, Ding Q, Gu J, Sfamenos SM, et al
    Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?
    Clin Breast Cancer. 2023 Feb 12:S1526-8209(23)00037.
    PubMed     Abstract available


  189. YANG R, Dong C, Jiang T, Zhang X, et al
    Indocyanine Green and Methylene Blue Dye Guided Sentinel Lymph Node Biopsy in Early Breast Cancer: A Single-Center Retrospective Survival Study in 1574 Patients.
    Clin Breast Cancer. 2023 Feb 11:S1526-8209(23)00032.
    PubMed     Abstract available


  190. DU J, Wu K
    PCDHA1 High Expression is Associated With Poor Prognosis and Correlated With Immune Cell Infiltration in Breast Cancer.
    Clin Breast Cancer. 2023 Feb 10:S1526-8209(23)00031.
    PubMed     Abstract available


  191. TANG ZN, Bi XF, Chen WL, Zhang CL, et al
    RANKL Promotes Chemotherapy Resistance in Breast Cancer Cells Through STAT3 Mediated Autophagy Induction.
    Clin Breast Cancer. 2023 Feb 7:S1526-8209(23)00030.
    PubMed     Abstract available


  192. ZHANG M, Ma N, Wang R
    Mendelian Randomization Study on Causal Association of IL-6With Breast Cancer.
    Clin Breast Cancer. 2023 Feb 5:S1526-8209(23)00029.
    PubMed     Abstract available


  193. BARI S, Li J, Kang D, Jameel Z, et al
    A Real-World Data Retrospective Cohort Study of HER2-positive, Early-Stage Breast Cancer in Patients 70 Years of Age or Older: Natural History, Treatment Patterns, and Outcomes.
    Clin Breast Cancer. 2023 Feb 4:S1526-8209(23)00028.
    PubMed     Abstract available


  194. PAGLIARA D, Montella RA, Garganese G, Bove S, et al
    Improving Decision-making in Prepectoral Direct-to-implant Reconstruction After Nipple Sparing Mastectomy: The Key Role of Flap Thickness Ratio.
    Clin Breast Cancer. 2023;23:e37-e44.
    PubMed     Abstract available


  195. HA M, Ngaage LM, Finkelstein ER, Klein M, et al
    Insurance Coverage of Prophylactic Mastectomies: A National Review of the United States.
    Clin Breast Cancer. 2023;23:211-218.
    PubMed     Abstract available


  196. LERNER G, Tang H, Singh K, Golestani R, et al
    AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasive Apocrine Breast Cancers.
    Clin Breast Cancer. 2023;23:199-210.
    PubMed     Abstract available


  197. BENTLEY H, Roberts J, Hayes M, Wilson C, et al
    The Role of Imaging in the Diagnosis of Primary and Secondary Breast Angiosarcoma: Twenty-Five-Year Experience of a Provincial Cancer Institution.
    Clin Breast Cancer. 2023;23:e45-e53.
    PubMed     Abstract available


  198. MADAN V, Mamounas EP
    Is Sentinel Lymph Node Biopsy Necessary in Patients who Undergo Prophylactic Mastectomy?
    Clin Breast Cancer. 2023;23:231-236.
    PubMed     Abstract available


  199. SAYAN M, Kilic S, Zhang Y, Liu B, et al
    Early Toxicity and Patient-Reported Cosmetic Outcomes in Patients Treated With Adjuvant Proton-Based Radiotherapy After Breast-Conserving Surgery.
    Clin Breast Cancer. 2023;23:176-180.
    PubMed     Abstract available


  200. WARD KA, Muller DA, Dutta SW, Malhi J, et al
    Long-Term Adherence to Adjuvant Endocrine Therapy Following Various Radiotherapy Modalities in Early Stage Hormone Receptor Positive Breast Cancer.
    Clin Breast Cancer. 2023 Feb 1:S1526-8209(23)00027.
    PubMed     Abstract available


    January 2023
  201. ALTUNDAG K
    Is Taxane Rechallenge Time Dependent in Patients With Advanced Triple-Negative Breast Cancer?
    Clin Breast Cancer. 2023 Jan 25:S1526-8209(23)00020.
    PubMed    


  202. FUENTES-ABOLAFIO IJ, Roldan-Jimenez C, Campos MI, Pajares-Hachero BI, et al
    Forearm Muscle Activity During the Handgrip Test in Breast Cancer Survivors: A Cross-Sectional Study.
    Clin Breast Cancer. 2023 Jan 20:S1526-8209(23)00018.
    PubMed     Abstract available


  203. RAZETI MG, Soldato D, Arecco L, Levaggi A, et al
    Approaches to Fertility Preservation for Young Women With Breast Cancer.
    Clin Breast Cancer. 2023 Jan 14:S1526-8209(23)00006.
    PubMed     Abstract available


  204. MIYAMOTO N, Inoue H, Inui T, Sasa S, et al
    Absolute Lymphocyte Count Changes During Neoadjuvant Chemotherapy are Associated With Prognosis of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Patients.
    Clin Breast Cancer. 2023 Jan 12:S1526-8209(23)00005.
    PubMed     Abstract available


  205. ZHOU HL, Chen DD
    Prognosis of Patients With Triple-negative Breast Cancer: A Population-based Study From SEER Database.
    Clin Breast Cancer. 2023 Jan 11:S1526-8209(23)00001.
    PubMed     Abstract available


  206. ADACHI K, Kimura F, Takahashi H, Kaise H, et al
    Delayed Diagnosis and Prognostic Impact of Breast Cancer During the COVID-19 Pandemic.
    Clin Breast Cancer. 2023 Jan 10:S1526-8209(23)00002.
    PubMed     Abstract available


  207. SURENDRAN AM, Rai A, Rakshit S, George M, et al
    Immunomodulatory Role of Diospyros peregrina Fruit Preparation in Breast Cancer by Utilizing Macrophage Mediated Antigen Presentation and T Helper Cell (Th) Differentiation.
    Clin Breast Cancer. 2023 Jan 6:S1526-8209(22)00311.
    PubMed     Abstract available


  208. CO M, Lam L, Suen D, Kwong A, et al
    Axillary Reverse Mapping in the Prevention of Lymphoedema: A Systematic Review and Pooled Analysis.
    Clin Breast Cancer. 2023;23:e14-e19.
    PubMed     Abstract available


  209. FOSKO NK, Gribkova Y, Krupa K, Bs KJ, et al
    The Use of Intraoperative Ultrasound During Breast Conserving Surgery.
    Clin Breast Cancer. 2023;23:54-59.
    PubMed     Abstract available


    December 2022
  210. ALMAWI WY, Zidi S, Sghaier I, El-Ghali RM, et al
    Novel Association of IGF2BP2 Gene Variants With Altered Risk of Breast Cancer and as Potential Molecular Biomarker of Triple Negative Breast Cancer.
    Clin Breast Cancer. 2022 Dec 30:S1526-8209(22)00308.
    PubMed     Abstract available


  211. DE OLIVEIRA LM, Garcia HO, Curvello KD, Rebelatto TF, et al
    Letter to the Editor of Clinical Breast Cancer, on "Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review," Conducted by Michelle Bradbury and Collaborators and Published in Clin
    Clin Breast Cancer. 2022 Dec 28:S1526-8209(22)00309.
    PubMed    


  212. PENG C, Wu K, Chen X, Lang H, et al
    Migraine and Risk of Breast Cancer: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2022 Dec 25:S1526-8209(22)00289.
    PubMed     Abstract available


  213. ZHANG Z, Li F, Li Y, Li Z, et al
    In vitro Anti-malignant Property of PCMT1 Silencing and Identification of the SNHG16/miR-195/PCMT1 Regulatory Axis in Breast Cancer Cells.
    Clin Breast Cancer. 2022 Dec 24:S1526-8209(22)00291.
    PubMed     Abstract available


  214. SUN L, Chen S, Wang T, Bi S, et al
    Hsa_circ_0008673 Promotes Breast Cancer Progression by MiR-578/GINS4 Axis.
    Clin Breast Cancer. 2022 Dec 23:S1526-8209(22)00292.
    PubMed     Abstract available


  215. YANG C, Wang M, Huang R, Ou L, et al
    Circ_0108942 Regulates the Progression of Breast Cancer by Regulating the MiR-1178-3p/TMED3 Axis.
    Clin Breast Cancer. 2022 Dec 23:S1526-8209(22)00293.
    PubMed     Abstract available


  216. LEWINSOHN R, Zheng Y, Rosenberg SM, Ruddy KJ, et al
    Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Noncarriers.
    Clin Breast Cancer. 2022 Dec 22:S1526-8209(22)00290.
    PubMed     Abstract available


  217. HAN Y, Fu Y, Shi Q, Liu H, et al
    The ALDH2, IGSF9, and PRDM16 Proteins as Predictive Biomarkers for Prognosis in Breast Cancer.
    Clin Breast Cancer. 2022 Dec 21:S1526-8209(22)00287.
    PubMed     Abstract available


  218. EL-KHAZRAGY N, Gaballah A, Bakkar A, Hemida EHA, et al
    PTEN rs701848 Polymorphism is Associated with Trastuzumab Resistance in HER2-positive Metastatic Breast Cancer and Predicts Progression-free Survival.
    Clin Breast Cancer. 2022 Dec 20:S1526-8209(22)00288.
    PubMed     Abstract available


  219. LOBEFARO R, Mariani L, Peverelli G, Ligorio F, et al
    Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison.
    Clin Breast Cancer. 2022 Dec 17:S1526-8209(22)00286.
    PubMed     Abstract available


  220. CHEN JH, Canner JK, Myers K, Camp M, et al
    Concomitant Use of Biopsy Clips and Wire Localization in Invasive Breast Cancer is Associated With Successful Clip Retrieval.
    Clin Breast Cancer. 2022 Dec 16:S1526-8209(22)00285.
    PubMed     Abstract available


  221. SHAH AN, Santa-Maria CA, Mukhija D, Shah N, et al
    A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases.
    Clin Breast Cancer. 2022 Dec 15:S1526-8209(22)00283.
    PubMed     Abstract available


  222. KOMENAKA IK, Hsu CH, Ramos GM, Nodora J, et al
    Post Treatment Mastalgia is a Common Complaint but not an Indication of Recurrence or Second Primary Breast Cancer.
    Clin Breast Cancer. 2022 Dec 14:S1526-8209(22)00282.
    PubMed     Abstract available


  223. BIABANI ARDAKANI J, Abedi SM, Mardanshahi A, Shojaee L, et al
    Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [(99m)Tc] Tc-Labeled Small Peptide.
    Clin Breast Cancer. 2022 Dec 9:S1526-8209(22)00270.
    PubMed     Abstract available


  224. CATANEO JL, Meidl H, Ore AS, Raicu A, et al
    The Impact of Limited Language Proficiency in Screening for Breast Cancer.
    Clin Breast Cancer. 2022 Dec 6:S1526-8209(22)00264.
    PubMed     Abstract available


  225. YANG B, Wang YW, Qian LH, Xu Y, et al
    Downregulated miR-367-3p, miR-548aq-5p, and miR-4710 in Human Whole Blood: Potential Biomarkers for Breast Cancer With Axillary Lymph Node Metastasis.
    Clin Breast Cancer. 2022 Dec 5:S1526-8209(22)00267.
    PubMed     Abstract available


  226. DAVEY MG, Keelan S, Lowery AJ, Kerin MJ, et al
    The Impact of Chemotherapy Prescription on Long-Term Survival Outcomes in Early-Stage Invasive Lobular Carcinoma - A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2022;22:e843-e849.
    PubMed     Abstract available


  227. HUGHES RT, Ip EH, Urbanic JJ, Hu JJ, et al
    Smoking and Radiation-induced Skin Injury: Analysis of a Multiracial, Multiethnic Prospective Clinical Trial.
    Clin Breast Cancer. 2022;22:762-770.
    PubMed     Abstract available


  228. BRORSON F, Elander A, Thorarinsson A, Hansson E, et al
    Patient Reported Outcome and Quality of Life After Delayed Breast Reconstruction - An RCT Comparing Different Reconstructive Methods in Radiated and Non-radiated Patients.
    Clin Breast Cancer. 2022;22:753-761.
    PubMed     Abstract available


  229. HENG SSL, Gan YH, Yahya MM, Haron J, et al
    Changes in Spinal Alignment of Women Who Underwent Unilateral Mastectomy with Immediate Autologous Breast Reconstruction Compared To Mastectomy without Breast Reconstruction.
    Clin Breast Cancer. 2022;22:e863-e873.
    PubMed     Abstract available


  230. GOTLAND N, Loya A, Lanng C, Ronning H, et al
    Radiation Induced Atypical Vascular Lesion in the Breast.
    Clin Breast Cancer. 2022;22:e874-e876.
    PubMed     Abstract available


  231. ACAR E, Esendagli G, Yazici O, Dursun A, et al
    Tumor-Infiltrating Lymphocytes (TIL), Tertiary Lymphoid Structures (TLS), and Expression of PD-1, TIM-3, LAG-3 on TIL in Invasive and In Situ Ductal Breast Carcinomas and Their Relationship with Prognostic Factors.
    Clin Breast Cancer. 2022;22:e901-e915.
    PubMed     Abstract available


  232. SELFRIDGE JM, Sinner HF, Whiting J, Sun W, et al
    Effect of Microporous Polysaccharide Particles in Patients Undergoing Mastectomy.
    Clin Breast Cancer. 2022;22:e922-e927.
    PubMed     Abstract available


  233. DUDLEY CM, Stankowski TJ, Tucholka JL, Schumacher JR, et al
    Perspectives of Wisconsin Providers on Factors Influencing Receipt of Post-Mastectomy Breast Reconstruction.
    Clin Breast Cancer. 2022;22:840-846.
    PubMed     Abstract available


  234. RUAN D, Sun L
    Diagnostic Performance of PET/MRI in Breast Cancer: A Systematic Review and Bayesian Bivariate Meta-analysis.
    Clin Breast Cancer. 2022 Dec 1:S1526-8209(22)00266.
    PubMed     Abstract available


    November 2022
  235. LI J, Gao R, Zhang J
    USP22 Contributes to Chemoresistance, Stemness, and EMT Phenotype of Triple-Negative Breast Cancer Cells by egulating the Warburg Effect via c-Myc Deubiquitination.
    Clin Breast Cancer. 2022 Nov 25:S1526-8209(22)00262.
    PubMed     Abstract available


  236. CHOUCAIR K, Page SJ, Mattar BI, Dakhil CS, et al
    Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience.
    Clin Breast Cancer. 2022 Nov 23:S1526-8209(22)00261.
    PubMed     Abstract available


  237. CHEN Z, Gong X, Cheng C, Fu Y, et al
    Circ_0001777 Affects Triple-negative Breast Cancer Progression Through the miR-95-3p/AKAP12 Axis.
    Clin Breast Cancer. 2022 Nov 19:S1526-8209(22)00249.
    PubMed     Abstract available


  238. BARCO I, Chabrera C, Garcia-Fernandez A, Fraile M, et al
    COVID-19 Incidence and Mortality in Patients Operated on for Breast Cancer. Comparison with the General Population.
    Clin Breast Cancer. 2022 Nov 17:S1526-8209(22)00247.
    PubMed     Abstract available


  239. MENESES AFP, Pimentel FF, da Cruz JPF, Candido Dos Reis FJ, et al
    Experiences of Women With Breast Cancer Using Telehealth: A Qualitative Systematic Review.
    Clin Breast Cancer. 2022 Nov 12:S1526-8209(22)00246.
    PubMed     Abstract available


  240. MISER-SALIHOGLU E, Demokan S, Karanlik H, Karahalil B, et al
    Investigation of mRNA Expression Levels of Tip60 and Related DNA Repair Genes in Molecular Subtypes of Breast Cancer.
    Clin Breast Cancer. 2022 Nov 12:S1526-8209(22)00235.
    PubMed     Abstract available


    October 2022
  241. LIU X, Tao L, Wang M, Li H, et al
    ABSDELL Model: Development and Internal Validation of a Risk Prediction Model of LVEF Decline in Breast Cancer Patients Treated With Trastuzumab.
    Clin Breast Cancer. 2022 Oct 23. pii: S1526-8209(22)00234.
    PubMed     Abstract available


  242. TORRES-BALANZA S, Fuentes-Aparicio L, Mena-Del Horno S, Martinez-Aspas A, et al
    Sexual Perception in Spanish Female Breast Cancer Survivors. Cross-Sectional Survey.
    Clin Breast Cancer. 2022 Oct 21. pii: S1526-8209(22)00233.
    PubMed     Abstract available


  243. LI ZH, Hong WJ, Guo XL, Li XR, et al
    Serratus Plane Block in Breast Cancer Surgery: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2022 Oct 19. pii: S1526-8209(22)00231.
    PubMed     Abstract available


  244. ZHENG H, Yang L, Hu J, Yang Y, et al
    Frequency and Influencing Factors of Shared Decision Making Among Breast Cancer Patients Receiving Surgery: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2022 Oct 18. pii: S1526-8209(22)00230.
    PubMed     Abstract available


  245. KIM YE, Cha JH, Kim HH, Shin HJ, et al
    The Accuracy of Mammography, Ultrasound, and Magnetic Resonance Imaging For the Measurement of Invasive Breast Cancer With Extensive Intraductal Components.
    Clin Breast Cancer. 2022 Oct 13. pii: S1526-8209(22)00227.
    PubMed     Abstract available


  246. ALDRICH J, Ekpo P, Rupji M, Switchenko JM, et al
    Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical Center.
    Clin Breast Cancer. 2022 Oct 13. pii: S1526-8209(22)00229.
    PubMed     Abstract available


  247. MARTIN S, Pflumio C, Trensz P, Schaff-Wendling F, et al
    Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak.
    Clin Breast Cancer. 2022 Oct 13:S1526-8209(22)00228.
    PubMed     Abstract available


  248. PURSWANI JM, Nwankwo C, Adotama P, Gutierrez D, et al
    Radiation-induced skin changes after breast or chest wall irradiation in patients with breast cancer and skin of color: a systematic review.
    Clin Breast Cancer. 2022 Oct 8. pii: S1526-8209(22)00225.
    PubMed     Abstract available


  249. MEDIONI J, Scimeca D, Marquez YL, Leray E, et al
    Benefits of Homeopathic Complementary Treatment in Patients With Breast Cancer: A Retrospective Cohort Study Based on the French Nationwide Healthcare Database.
    Clin Breast Cancer. 2022 Oct 8. pii: S1526-8209(22)00224.
    PubMed     Abstract available


  250. ROY N, Villavisanis DF, Taub PJ
    Mitigating Financial Toxicity in Breast Cancer From Diagnosis to Treatment and Reconstruction.
    Clin Breast Cancer. 2022 Oct 4. pii: S1526-8209(22)00223.
    PubMed     Abstract available


  251. CARMON E, Alster T, Maly B, Kadouri L, et al
    Preoperative MRI for Evaluation of Extent of Disease in IDC Compared to ILC.
    Clin Breast Cancer. 2022;22:e745-e752.
    PubMed     Abstract available


  252. VIGGIANO T, Scott R, Sharpe R, Kasper C, et al
    Contrast Enhanced Mammography in Routine Clinical Practice: Frequency and Malignancy Rates of Enhancing Otherwise Occult Findings.
    Clin Breast Cancer. 2022;22:e736-e744.
    PubMed     Abstract available


  253. OSMAN MH, Rabie NA, Elmehrath AO, Bedair HM, et al
    Primary and Secondary Breast Sarcoma: Clinical and Pathological Characteristics, Prognostic Factors, and Nomograms for Predicting Survival.
    Clin Breast Cancer. 2022;22:e753-e763.
    PubMed     Abstract available


  254. GORDON PB
    Clinical Breast Examination is Important in Surveillance After Mastectomy.
    Clin Breast Cancer. 2022;22:e728.
    PubMed    


  255. FEI F, Siegal GP, Wei S
    Characterizing Clinicopathologic Features of Estrogen Receptor-Positive/Progesterone Receptor-Negative Breast Cancers.
    Clin Breast Cancer. 2022;22:e788-e797.
    PubMed     Abstract available


  256. CHEVLI N, Wang K, Haque W, Schwartz MR, et al
    Prognostic Impact of Radiation Therapy in Pure Mucinous Breast Carcinoma.
    Clin Breast Cancer. 2022;22:e807-e817.
    PubMed     Abstract available


  257. HENNESSY G, Boland MR, Bambrick M, Crone L, et al
    Value of Long-term Follow-up in Surgically Excised Lesions of Uncertain Malignant Potential in the Breast - Is 5 Years Necessary?
    Clin Breast Cancer. 2022;22:699-704.
    PubMed     Abstract available


  258. CORADINI D, Ambrogi F
    Differential Expression of the Genes Coding for Adipokines and Epithelial Cell Polarity Components in Women With Low and High Mammographic Density.
    Clin Breast Cancer. 2022;22:715-723.
    PubMed     Abstract available


  259. XU S, Luo W, Li M, Li Q, et al
    Circ_0001667 Promotes Adriamycin Resistance and Malignant Progression via Targeting the miR-193a-5p/Rap2A Molecular Axis in Breast Cancer.
    Clin Breast Cancer. 2022 Oct 1. pii: S1526-8209(22)00222.
    PubMed     Abstract available


    September 2022
  260. VAN HOUDT M, Han SN, Pauwels S, Billen J, et al
    Measurable Serum Estradiol and Estrone in Women 36-56 Years During Adjuvant Treatment With Aromatase Inhibitors for a Hormone Receptor-Positive Breast Cancer. Case Studies and Cross-sectional Study Using an Ultra-sensitive LC-MS/MS-Method.
    Clin Breast Cancer. 2022 Sep 28. pii: S1526-8209(22)00221.
    PubMed     Abstract available


  261. YADAV R, Kumar Y, Dahiya D, Bhatia A, et al
    Claudins: The Newly Emerging Targets in Breast Cancer.
    Clin Breast Cancer. 2022 Sep 9. pii: S1526-8209(22)00193.
    PubMed     Abstract available


  262. SINGH J, Sangwan N, Chauhan A, Avti PK, et al
    Integrative Expression, Survival Analysis and Cellular miR-2909 Molecular Interplay in MRN Complex Check Point Sensor Genes (MRN-CSG) Involved in Breast Cancer.
    Clin Breast Cancer. 2022 Sep 9. pii: S1526-8209(22)00192.
    PubMed     Abstract available


  263. ZHOU C, Xu L, Du Z, Lv Q, et al
    Geriatric Early-Stage Triple-Negative Breast Cancer Patients in Low-risk Population: Omitting Chemotherapy Based on Nomogram.
    Clin Breast Cancer. 2022 Sep 1. pii: S1526-8209(22)00190.
    PubMed     Abstract available


  264. HENDRIX N, Oestreicher N, Lalla D, Dolan CM, et al
    Residual Disease Burden After Neoadjuvant Therapy Among US Patients With High-Risk HER2-positive Early-Stage Breast Cancer: A Population Effectiveness Model.
    Clin Breast Cancer. 2022 Sep 1. pii: S1526-8209(22)00189.
    PubMed     Abstract available


    August 2022
  265. BARCO I, Garcia-Fdez A, Vallejo E, Tarroch X, et al
    Intraoperative Sentinel Node Fine-Needle Aspiration Biopsy as a Substitute for Whole Sentinel Node Excisional Biopsy in Breast Cancer Patients. Initial Report.
    Clin Breast Cancer. 2022 Aug 30. pii: S1526-8209(22)00185.
    PubMed     Abstract available


  266. WONG V, de Boer R, Baron-Hay S, Blum R, et al
    Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2022 Aug 30. pii: S1526-8209(22)00188.
    PubMed     Abstract available


  267. EDMONDS MC, Kim SJ, Wells M, Dahman B, et al
    A Mixed Method Approach to Examine Surveillance Mammography Experiences in Black and White Breast Cancer Survivors.
    Clin Breast Cancer. 2022 Aug 27. pii: S1526-8209(22)00186.
    PubMed     Abstract available


  268. NARUI K, Miura D, Hasegawa Y, Tachibana A, et al
    A Randomized Controlled Phase 2 Study of Neoadjuvant Eribulin Versus Paclitaxel in Women with Operable Breast Cancer: The JONIE-3 Study.
    Clin Breast Cancer. 2022 Aug 22. pii: S1526-8209(22)00184.
    PubMed     Abstract available


  269. BONADIO RC, Costa FA, Mendes SV, Araujo BJ, et al
    Disease Behavior and Treatment Response of Special Histological Types of Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2022 Aug 20. pii: S1526-8209(22)00182.
    PubMed     Abstract available


  270. DENG SX, Castelo M, Reel E, Naganathan G, et al
    High Risk Breast Cancer Screening is a Double Edged Sword: A Qualitative Study of Patient Perspectives on the Ontario High Risk Breast Cancer Screening Program.
    Clin Breast Cancer. 2022 Aug 19. pii: S1526-8209(22)00183.
    PubMed     Abstract available


  271. KOZAK MM, Karl J, von Eyben R, Guo F, et al
    Incidence of Brain Metastases in Women Treated With Neoadjuvant Chemotherapy for Breast Cancer: Implications for Screening.
    Clin Breast Cancer. 2022 Aug 11. pii: S1526-8209(22)00180.
    PubMed     Abstract available


  272. SHAH S, Shaing C, Khatib J, Lodrigues W, et al
    The Utility of Breast Cancer Index (BCI) Over Clinical Prognostic Tools for Predicting the Need for Extended Endocrine Therapy: A Safety Net Hospital Experience.
    Clin Breast Cancer. 2022 Aug 11. pii: S1526-8209(22)00179.
    PubMed     Abstract available


  273. TUGRAL A, Bakar Y, Akyol M
    The Characteristics of Pain Tolerance in Patients Who Underwent Unilateral Breast Cancer Surgery: The Effect of Handedness and Surgical Site to Assess the Potential Musculoskeletal Symptoms and Function.
    Clin Breast Cancer. 2022 Aug 6. pii: S1526-8209(22)00178.
    PubMed     Abstract available


  274. FERNANDEZ PEREZ I, Tunas LV, Corbacho DP, Benito CG, et al
    Utility of Genomic Platforms in Treatment Decisions in Axilla-Positive Breast Cancer.
    Clin Breast Cancer. 2022 Aug 5. pii: S1526-8209(22)00176.
    PubMed     Abstract available


  275. CHARATI FG, Shojaee L, Haghighat S, Esmaeili R, et al
    Motor Exercises Effect on Improving Shoulders Functioning, Functional Ability, Quality of Life, Depression and Anxiety For Women With Breast Cancer.
    Clin Breast Cancer. 2022 Aug 3. pii: S1526-8209(22)00171.
    PubMed     Abstract available


  276. YEP MANZANO IS, Agrawal A
    A Comparative Study of Drain in Oncoplastic Breast Conserving Surgery (Therapeutic Mammaplasty and Chest Wall Perforator Flap Partial Breast Reconstruction) vs. Mastectomy.
    Clin Breast Cancer. 2022;22:619-627.
    PubMed     Abstract available


  277. USLU H, Tosun M
    The benefit of superb microvascular imaging and shear wave elastography in differentiating metastatic axillary lymphadenopathy from lymphadenitis.
    Clin Breast Cancer. 2022;22:515-520.
    PubMed     Abstract available


  278. FREBAULT J, Bergom C, Cortina CS, Shukla ME, et al
    Treatment Patterns in Women Age 80 and Over With DCIS: A Report From the National Cancer Database.
    Clin Breast Cancer. 2022;22:547-552.
    PubMed     Abstract available


  279. SAYAN M, Kilic SS, Vergalasova I, Jan I, et al
    Risk Factors for the Development of Clinical and Subclinical Lymphedema Detected by Bioimpedance Spectroscopy.
    Clin Breast Cancer. 2022;22:553-559.
    PubMed     Abstract available


    July 2022
  280. WILLIAMS AD, Solis O, Sterbling HM, Murray A, et al
    Are We Overtreating Patients With T1a HER2+ Breast Cancer? An Analysis of the National Cancer Database.
    Clin Breast Cancer. 2022 Jul 29. pii: S1526-8209(22)00175.
    PubMed     Abstract available


  281. ALTUNDAG K
    Combination Treatment of Vinorelbine With Oral Cyclophosphamide or Capecitabine or Both Might Overcome Cross-resistance Against Eribulin in Advanced Breast Cancer.
    Clin Breast Cancer. 2022 Jul 25. pii: S1526-8209(22)00173.
    PubMed    


  282. TUNG I, Moldovan C, Wong V, De Boer R, et al
    Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study.
    Clin Breast Cancer. 2022 Jul 14. pii: S1526-8209(22)00155.
    PubMed     Abstract available


  283. MURCHISON S, Nichol A, Speers C, Gondara L, et al
    Locoregional Recurrence and Survival Outcomes in Breast Cancer Treated With Modern Neoadjuvant Chemotherapy: A Contemporary Population-based Analysis.
    Clin Breast Cancer. 2022 Jul 12. pii: S1526-8209(22)00145.
    PubMed     Abstract available


  284. SHARMA A, Searle K, Hasan S, Chan S, et al
    Exclusion of Patients With Brain Metastases in Published Phase III Clinical Trials for Advanced Breast Cancer.
    Clin Breast Cancer. 2022 Jul 11. pii: S1526-8209(22)00154.
    PubMed     Abstract available


  285. LAN B, Lv D, Sun X, Yang M, et al
    Genetic Variations in IFNGR1, BDNF and IL-10 May Predict the Susceptibility to Depression and Anxiety in Chinese Women With Breast Cancer.
    Clin Breast Cancer. 2022 Jul 9. pii: S1526-8209(22)00144.
    PubMed     Abstract available


  286. WANG J, Li Q, Luo Y, Han Y, et al
    Development and External Validation of a Clinical Nomogram for Individually Predicting Survival of Metaplastic Breast Cancer.
    Clin Breast Cancer. 2022 Jul 9. pii: S1526-8209(22)00142.
    PubMed     Abstract available


  287. VATHIOTIS IA, Trontzas I, Gavrielatou N, Gomatou G, et al
    Immune Checkpoint Blockade in Hormone Receptor-Positive Breast Cancer: Resistance Mechanisms and Future Perspectives.
    Clin Breast Cancer. 2022 Jul 7. pii: S1526-8209(22)00140.
    PubMed     Abstract available


  288. MORAES MO, Forte GC, Guimaraes ADSG, Grando MBFDP, et al
    Breast MRI: Simplifying Protocol and BI-RADS Categories.
    Clin Breast Cancer. 2022;22:e615-e622.
    PubMed     Abstract available


  289. DE VITA R, Villanucci A, Buccheri EM, Pozzi M, et al
    Extended Clinical Experience With Nipple-Sparing Mastectomy and Prepectoral Polyurethane Implant Positioning (BRAND4P method).
    Clin Breast Cancer. 2022;22:e623-e628.
    PubMed     Abstract available


  290. MICHA A, Parvaiz MA, O'Riordan L, MacNeill F, et al
    Isotope-Only Localization for Sentinel Lymph Node Biopsy - Medium-Term Oncological Outcomes.
    Clin Breast Cancer. 2022;22:e636-e640.
    PubMed     Abstract available


  291. XIE Y, Wang Q, Hu T, Chen R, et al
    Effect of a Novel Soaking Solution Used in Patients With Hand-Foot Syndrome as a Result of Capecitabine Treatment: A Randomized and Self-Controlled Trial.
    Clin Breast Cancer. 2022;22:e685-e690.
    PubMed     Abstract available


  292. OMISORE AD, Odedeyi AA, Famurewa OC, Olasehinde O, et al
    Practice, Perceptions, and Prospects of Mammography Screening in Nigeria: Insights From a National Survey of Female Health Workers.
    Clin Breast Cancer. 2022;22:462-472.
    PubMed     Abstract available


  293. TANVEER N, Dixit S, Jain P, Rani P, et al
    Static smartphone images supplemented by videoconferencing for breast telepathology.
    Clin Breast Cancer. 2022;22:455-461.
    PubMed     Abstract available


  294. MAYROVITZ HN, Weingrad DN
    Tissue Dielectric Constant Differentials between Malignant and Benign Breast Tumors.
    Clin Breast Cancer. 2022;22:473-477.
    PubMed     Abstract available


  295. AROLE V, Shafi S, Challa B, Parwani AV, et al
    Evaluating Mismatch Repair Status to Screen Clinical Advanced Breast Carcinomas for Immunotherapy: Experience From a Large Academic Institution.
    Clin Breast Cancer. 2022;22:e680-e684.
    PubMed     Abstract available


  296. KELLY BN, Webster AJ, Lamb L, Spivey T, et al
    Magnetic Seeds: An Alternative to Wire Localization for Nonpalpable Breast Lesions.
    Clin Breast Cancer. 2022;22:e700-e707.
    PubMed     Abstract available


    June 2022
  297. TUN SM, Alluri S, Rastegar V, Visintainer P, et al
    Mode of Detection of Second Events in Routine Surveillance of Early Stage Breast Cancer Patients.
    Clin Breast Cancer. 2022 Jun 29. pii: S1526-8209(22)00139.
    PubMed     Abstract available


  298. MENG X, Chang X, Wang X, Guo Y, et al
    Development and Validation a Survival Prediction Model and a Risk Stratification for Elderly Locally Advanced Breast Cancer.
    Clin Breast Cancer. 2022 Jun 26. pii: S1526-8209(22)00138.
    PubMed     Abstract available


  299. REDEMSKI T, Hamilton DG, Schuler S, Liang R, et al
    Rehabilitation for Women Undergoing Breast Cancer Surgery: A Systematic Review and Meta-Analysis of the Effectiveness of Early, Unrestricted Exercise Programs on Upper Limb Function.
    Clin Breast Cancer. 2022 Jun 24. pii: S1526-8209(22)00137.
    PubMed     Abstract available


  300. LIU H, Mei Y, Ma X, Zhang X, et al
    FRZB is Regulated by the Transcription Factor EGR1 and Inhibits the Growth and Invasion of Triple-Negative Breast Cancer Cells by Regulating the JAK/STAT3 Pathway.
    Clin Breast Cancer. 2022 Jun 2. pii: S1526-8209(22)00115.
    PubMed     Abstract available


  301. SHEIKH SE, Rathbone M, Chaudhary K, Joshi A, et al
    Rates and Outcomes of Breast Lesions of Uncertain Malignant Potential (B3) benchmarked against the National Breast Screening Pathology Audit; Improving Performance in a High Volume Screening Unit.
    Clin Breast Cancer. 2022;22:381-390.
    PubMed     Abstract available


  302. VRANIC S, Gatalica Z
    An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast.
    Clin Breast Cancer. 2022;22:e576-e585.
    PubMed     Abstract available


  303. PETROLLA A, Hicks DG, Skinner KA, Wang X, et al
    Detailed Morphologic Evaluation of Breast Papillary Lesions on Core Biopsy Is Critical for Accurate Classification and Clinical Management: The Experience of an Academic Institute.
    Clin Breast Cancer. 2022;22:e552-e557.
    PubMed     Abstract available


  304. GU Y, Tian J, Ran H, Ren W, et al
    Can Ultrasound Elastography Help Better Manage Mammographic BI-RADS Category 4 Breast Lesions?
    Clin Breast Cancer. 2022;22:e407-e416.
    PubMed     Abstract available


    May 2022
  305. OKINES AFC, Irfan T, Mohammed K, Ring A, et al
    Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-Resistance.
    Clin Breast Cancer. 2022 May 27. pii: S1526-8209(22)00113.
    PubMed     Abstract available


  306. MICELI R, Cao C, Maolanon NN, Jacobs R, et al
    Plasma Profile of Immune Determinants Predicts Pathological Complete Response in Locally Advanced Breast Cancer Patients: A Pilot Study.
    Clin Breast Cancer. 2022 May 23. pii: S1526-8209(22)00112.
    PubMed     Abstract available


  307. HOUZARD S, Courtois E, Le Bihan Benjamin C, Erbault M, et al
    Monitoring Breast Cancer Care Quality at National and Local Level Using the French National Cancer Cohort.
    Clin Breast Cancer. 2022 May 21. pii: S1526-8209(22)00096.
    PubMed     Abstract available


  308. MALLA R, Puvalachetty K, Vempati RK, Marni R, et al
    Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis.
    Clin Breast Cancer. 2022 May 19. pii: S1526-8209(22)00094.
    PubMed     Abstract available


  309. PATT D, Liu X, Li B, McRoy L, et al
    Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis.
    Clin Breast Cancer. 2022 May 5. pii: S1526-8209(22)00081.
    PubMed     Abstract available


  310. POTERALA JE, Havighurst T, Braun Wisinski K
    Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment Strategies.
    Clin Breast Cancer. 2022 May 5. pii: S1526-8209(22)00080.
    PubMed     Abstract available


    April 2022
  311. HEYLEN J, Punie K, Smeets A, Neven P, et al
    Elevated CA 15.3 in Newly Diagnosed Breast Cancer: A Retrospective Study.
    Clin Breast Cancer. 2022 Apr 30. pii: S1526-8209(22)00076.
    PubMed     Abstract available


  312. TONG QY, Liu R, Gao Y, Zhang K, et al
    Effect of Electroacupuncture Based on ERAS for Preoperative Anxiety in Breast Cancer Surgery: A Single-Center, Randomized, Controlled Trial.
    Clin Breast Cancer. 2022 Apr 30. pii: S1526-8209(22)00079.
    PubMed     Abstract available


  313. SNIDER K, Moore T, Walters C, Brachtenbach T, et al
    An Analysis of the Evidence Informing Clinical Practice Guidelines in the Management and Treatment of Breast Cancer.
    Clin Breast Cancer. 2022 Apr 29. pii: S1526-8209(22)00078.
    PubMed     Abstract available


  314. ARIFFIN NS
    RUNX1 as a Novel Molecular Target for Breast Cancer.
    Clin Breast Cancer. 2022 Apr 26. pii: S1526-8209(22)00075.
    PubMed     Abstract available


  315. MEHRAJ U, Alshehri B, Khan AA, Bhat AA, et al
    Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis.
    Clin Breast Cancer. 2022 Apr 25. pii: S1526-8209(22)00077.
    PubMed     Abstract available


  316. YAMADA D, Ohde S, Kajiura Y, Yagishita K, et al
    Relationship Between Breast Density, Breast Cancer Subtypes, and Prognosis.
    Clin Breast Cancer. 2022 Apr 22. pii: S1526-8209(22)00074.
    PubMed     Abstract available


  317. VANGURI RS, Fenn KM, Kearney MR, Wang Q, et al
    Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer.
    Clin Breast Cancer. 2022 Apr 18. pii: S1526-8209(22)00071.
    PubMed     Abstract available


  318. UDDIN MN, Wang X
    Identification of Breast Cancer Subtypes Based on Gene Expression Profiles in Breast Cancer Stroma.
    Clin Breast Cancer. 2022 Apr 5. pii: S1526-8209(22)00070.
    PubMed     Abstract available


  319. TWELVES C, Bartsch R, Ben-Baruch NE, Borstnar S, et al
    The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBC.
    Clin Breast Cancer. 2022;22:223-234.
    PubMed     Abstract available


  320. SHIN HJ, Choi WJ, Park SY, Ahn SH, et al
    Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy.
    Clin Breast Cancer. 2022;22:e374-e386.
    PubMed     Abstract available


  321. ZENG A, Brennan ME, Young S, Mathieu E, et al
    The Effect of Supplemental Imaging on Interval Cancer Rates in Mammography Screening: Systematic Review.
    Clin Breast Cancer. 2022;22:212-222.
    PubMed     Abstract available


  322. BRADBURY M, Hutton B, Beltran-Bless AA, Alzahrani M, et al
    Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review.
    Clin Breast Cancer. 2022;22:e362-e373.
    PubMed     Abstract available


  323. LIN X, He Y, Fu S, Lin S, et al
    The Ultrasonographic Characteristics of Focal Fibrocystic Change of the Breast and Analysis of Misdiagnosis.
    Clin Breast Cancer. 2022;22:252-260.
    PubMed     Abstract available


  324. LOTZ M, Ghebremichael M, Chervinsky K, Zorc T, et al
    Effective Surveillance of High-Risk Women.
    Clin Breast Cancer. 2022;22:e263-e269.
    PubMed     Abstract available


    March 2022
  325. HE Y, Gao X, Wu J, Li X, et al
    Effect of Breast Conservation Therapy vs Mastectomy on Overall Survival and Breast Cancer-Specific Survival Among Men With Stage I-II Breast Cancer: Analysis of SEER, 2000-2018.
    Clin Breast Cancer. 2022 Mar 31. pii: S1526-8209(22)00069.
    PubMed     Abstract available


  326. JACOBS W, Schagen SB, Brouwer SM, Kieffer JM, et al
    The Effects of Being Informed About Chemotherapy-Related Cognitive Symptoms With And Without Self-Affirmation on Perceived Cognitive Symptoms of Breast Cancer Patients: A Randomized Prospective, Longitudinal Study.
    Clin Breast Cancer. 2022 Mar 26. pii: S1526-8209(22)00064.
    PubMed     Abstract available


  327. MARCZYK VR, Rosa DD, Maia AL, Goemann IM, et al
    Overall Survival for HER2-Positive Breast Cancer Patients in the HER2-Targeted Era: Evidence From a Population-Based Study.
    Clin Breast Cancer. 2022 Mar 23. pii: S1526-8209(22)00066.
    PubMed     Abstract available


  328. JIANG C, Zhang S, Qiao K, Xiu Y, et al
    The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2022 Mar 21. pii: S1526-8209(22)00065.
    PubMed     Abstract available


  329. FENG M, Yang Y, Liao W, Li Q, et al
    Margetuximab Versus Trastuzumab in Patients With Advanced Breast Cancer: A Cost-effectiveness Analysis.
    Clin Breast Cancer. 2022 Mar 17. pii: S1526-8209(22)00063.
    PubMed     Abstract available


  330. ZHENG Y, Jiang X, Wang M, Yang S, et al
    BMPR1B Polymorphisms (rs1434536 and rs1970801) are Associated With Breast Cancer Susceptibility in Northwest Chinese Han Females: A Case-Control Study.
    Clin Breast Cancer. 2022 Mar 14. pii: S1526-8209(22)00045.
    PubMed     Abstract available


    February 2022
  331. ROSSO C, Voutsadakis IA
    Characteristics, Clinical Differences and Outcomes of Breast Cancer Patients with Negative or Low HER2 Expression.
    Clin Breast Cancer. 2022 Feb 26. pii: S1526-8209(22)00042.
    PubMed     Abstract available


  332. LIN Y, Yang Y, Zhang X, Li W, et al
    Manual Lymphatic Drainage for Breast Cancer-related Lymphedema: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2022 Feb 24. pii: S1526-8209(22)00034.
    PubMed     Abstract available


  333. LI L, Xiong Y, Wang N, Zhu M, et al
    Breast Cancer Stem Cells-derived Extracellular Vesicles Affect PPARG Expression by Delivering MicroRNA-197 in Breast Cancer Cells.
    Clin Breast Cancer. 2022 Feb 11. pii: S1526-8209(22)00040.
    PubMed     Abstract available


  334. CANINO F, Omarini C, Cerma K, Moscetti L, et al
    Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist.
    Clin Breast Cancer. 2022 Feb 7. pii: S1526-8209(22)00036.
    PubMed     Abstract available


  335. SONG Z, Li C, Zhou D, Liu J, et al
    Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated With Trimodality Therapy.
    Clin Breast Cancer. 2022 Feb 6. pii: S1526-8209(22)00035.
    PubMed     Abstract available


  336. LIBESMAN S, Zackrisson S, Hofvind S, Seidler AL, et al
    An individual participant data meta-analysis of breast cancer detection and recall rates for digital breast tomosynthesis versus digital mammography population screening.
    Clin Breast Cancer. 2022 Feb 6. pii: S1526-8209(22)00037.
    PubMed     Abstract available


  337. MACNAB MF, Slater G, Fuller M, Elsberger B, et al
    The Role of redo-Sentinel Lymph Node Biopsy in Patients With Prior Ipsilateral Breast Cancer Surgery.
    Clin Breast Cancer. 2022 Feb 3. pii: S1526-8209(22)00033.
    PubMed     Abstract available


  338. FISER CK, Kronenfeld JP, Liu SN, Goel N, et al
    Comparison of Immediate Breast Reconstruction Outcomes in Patients With and Without Prior Cosmetic Breast Surgery.
    Clin Breast Cancer. 2022;22:136-142.
    PubMed     Abstract available


  339. CHOE AI, Ismail R, Mack J, Walter V, et al
    Review of Variables Associated With Positive Surgical Margins Using Scout Reflector Localizations for Breast Conservation Therapy.
    Clin Breast Cancer. 2022;22:e232-e238.
    PubMed     Abstract available


  340. YI M, Peng C, Xia B, Gan L, et al
    CXCL8 Facilitates the Survival and Paclitaxel-Resistance of Triple-Negative Breast Cancers.
    Clin Breast Cancer. 2022;22:e191-e198.
    PubMed     Abstract available


  341. GUIRGUIS MS, Checka C, Adrada BE, Whitman GJ, et al
    Bracketing with Multiple Radioactive Seeds to Achieve Negative Margins in Breast Conservation Surgery: Multiple Seeds in Breast Surgery.
    Clin Breast Cancer. 2022;22:e158-e166.
    PubMed     Abstract available


    January 2022
  342. HAQUE W, Verma V, Schwartz MR, Lim B, et al
    Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: Response Rates, Management, and Outcomes.
    Clin Breast Cancer. 2022 Jan 31. pii: S1526-8209(22)00021.
    PubMed     Abstract available


  343. EL-BASSIOUNY NA, Helmy MW, Hassan MAE, Khedr GA, et al
    The Cardioprotective Effect of Vitamin D in Breast Cancer Patients Receiving Adjuvant Doxorubicin Based Chemotherapy.
    Clin Breast Cancer. 2022 Jan 31. pii: S1526-8209(22)00024.
    PubMed     Abstract available


  344. BILANI N, Ladki S, Yaghi M, Main O, et al
    Factors Associated With the Decision to Decline Chemotherapy in Patients With Early-stage, ER+/HER2- Breast Cancer and High-risk Scoring on Genomic Assays.
    Clin Breast Cancer. 2022 Jan 22. pii: S1526-8209(22)00023.
    PubMed     Abstract available


  345. LIU J, Yu H, Cui H, Wei F, et al
    lncRNA LINC000466 Predicts the Prognosis and Promotes the Progression of Triple-negative Breast Cancer via Modulating miR-539-5p.
    Clin Breast Cancer. 2022 Jan 22. pii: S1526-8209(22)00026.
    PubMed     Abstract available


  346. GHANBARI M, Shahinfar H, Imani H, Safabakhsh M, et al
    Association of Empirically Derived Food-Based Inflammatory Potential of the Diet and Breast Cancer: A Hospital-Based Case-Control Study.
    Clin Breast Cancer. 2022 Jan 21. pii: S1526-8209(21)00371.
    PubMed     Abstract available


  347. ISHII T, Nakano E, Watanabe T, Higashi T, et al
    Cardiac Function Checkup During Trastuzumab Therapy Among Patients With Breast Cancer.
    Clin Breast Cancer. 2022 Jan 19. pii: S1526-8209(22)00020.
    PubMed     Abstract available


  348. WILLIAMS AD, Ciocca R, Sabol JL, Carp NZ, et al
    The use of neoadjuvant therapy increases the rate of breast conservation in men with locally advanced breast cancer.
    Clin Breast Cancer. 2022 Jan 16. pii: S1526-8209(22)00019.
    PubMed     Abstract available


  349. GALINDO CM, Oliveira Ganzella FA, Klassen G, Souza Ramos EA, et al
    Nuances of PFKFB3 Signaling in Breast Cancer.
    Clin Breast Cancer. 2022 Jan 15. pii: S1526-8209(22)00017.
    PubMed     Abstract available


  350. MERFELD EC, Burr AR, Brickson C, Neuman HB, et al
    De-escalating Locoregional Therapy for Axillary Micrometastases in Breast Cancer: How Much is Too Much?
    Clin Breast Cancer. 2022 Jan 12. pii: S1526-8209(22)00016.
    PubMed     Abstract available


  351. HADALIN V, Pislar N, Borstnar S, Matos E, et al
    Intraoperative Touch Imprint Cytology in Breast Cancer Patients After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2022 Jan 5. pii: S1526-8209(21)00374.
    PubMed     Abstract available


  352. OBISPO B, Rogado J, Lara Alvarez MA
    The Other Cost of the Pandemic.
    Clin Breast Cancer. 2022;22:e108.
    PubMed    


  353. BERNINI M, Sordi S, Bembi N, Meattini I, et al
    Selective Denervation of Pectoralis Major Muscle Improves Cosmetic Outcome and Quality of Life in Retro-Pectoral Implant Based Breast Reconstruction.
    Clin Breast Cancer. 2022;22:60-66.
    PubMed     Abstract available


  354. KANG MM, Hasan Y, Waller J, Saulsberry L, et al
    Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database.
    Clin Breast Cancer. 2022;22:e8-e20.
    PubMed     Abstract available


  355. WANG C, Tsang JY, Poon IK, Shao Y, et al
    An Evaluation of Clinicopathological Correlation and Outcome of Human Epidermal Growth Factor Receptor 2 Subgroups Reclassified According to the Latest ASCO/CAP Guideline.
    Clin Breast Cancer. 2022;22:e114-e122.
    PubMed     Abstract available


  356. VARGHESE J, Gohari S, Regrag F, Rizki H, et al
    Breast Density Notification: Current UK National Practice.
    Clin Breast Cancer. 2022;22:e101-e107.
    PubMed     Abstract available


  357. KOH J, Yoon Y, Kim S, Han K, et al
    Deep Learning for the Detection of Breast Cancers on Chest Computed Tomography.
    Clin Breast Cancer. 2022;22:26-31.
    PubMed     Abstract available


  358. AZHAR S, Wyatt LC, Jokhakar V, Patel S, et al
    Associations between Spiritual Health Locus of Control, Perceived Discrimination and Breast and Cervical Cancer Screening for Muslim American Women in New York City.
    Clin Breast Cancer. 2022 Jan 1. pii: S1526-8209(21)00373.
    PubMed     Abstract available


    December 2021
  359. WALSH EM, Mangini N, Fetting J, Armstrong D, et al
    Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.
    Clin Breast Cancer. 2021 Dec 30. pii: S1526-8209(21)00358.
    PubMed     Abstract available


  360. RAMOS-MARTINEZ JC, Altamirano-Gomez G, Ramos-Martinez I, Valencia J, et al
    Prognostic Value of Galectin Expression in Patients with Breast Cancer: Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2021 Dec 29. pii: S1526-8209(21)00372.
    PubMed     Abstract available


  361. JERUSALEM G, Delea TE, Martin M, De Laurentiis M, et al
    Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR+/-HER2- Advanced Breast Cancer in the MONALEESA-3 Trial.
    Clin Breast Cancer. 2021 Dec 20. pii: S1526-8209(21)00369.
    PubMed     Abstract available


  362. KATHURIA-PRAKASH N, Antrim L, Hornstein N, Sun AW, et al
    Factors Associated With Hospitalization Among Breast Cancer Patients With COVID-19: A Diverse Multi-Center Los Angeles Cohort Study.
    Clin Breast Cancer. 2021 Dec 17. pii: S1526-8209(21)00356.
    PubMed     Abstract available


  363. DE GROEF A, Demeyer H, de Kinkelder C, Dukers-van Althuis S, et al
    Physical Activity Levels of Breast Cancer Patients Before Diagnosis Compared to a Reference Population: A Cross-Sectional Comparative Study.
    Clin Breast Cancer. 2021 Dec 16. pii: S1526-8209(21)00357.
    PubMed     Abstract available


  364. SHAFAEE MN, Makawita S, Lim B, Ellis MJ, et al
    Concurrent Chemo-radiation As a Means of Achieving Pathologic Complete Response in Triple Negative Breast Cancer.
    Clin Breast Cancer. 2021 Dec 14. pii: S1526-8209(21)00352.
    PubMed     Abstract available


  365. BIHAN-BENJAMIN CL, Bertrand C, Molinie F, Rogel A, et al
    Care pathway of women with interval breast cancer in 2016, based on medico-administrative data.
    Clin Breast Cancer. 2021 Dec 11. pii: S1526-8209(21)00353.
    PubMed     Abstract available


  366. WANG YS, Guo R, Yang DC, Xu Y, et al
    The Interaction of NTN4 and miR-17-92 Polymorphisms on Breast Cancer Susceptibility in a Chinese Population.
    Clin Breast Cancer. 2021 Dec 10. pii: S1526-8209(21)00354.
    PubMed     Abstract available


  367. ZOU H, Liu SH, Yang R, Wu XJ, et al
    Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of Breast Cancer and its Association With Pathological Features and Molecular Types.
    Clin Breast Cancer. 2021 Dec 3. pii: S1526-8209(21)00347.
    PubMed     Abstract available


  368. ANGARITA FA, Jedrzejko N, Eisen D, Muraca M, et al
    Primary Care Physicians' Perspectives in Leading Breast Cancer Follow-Up Care.
    Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00350.
    PubMed     Abstract available


  369. CAPARICA R, Ma Y, De Angelis C, Richard F, et al
    Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial.
    Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00351.
    PubMed     Abstract available


  370. MACHUCA MPG, Wu WC, Yu BL, Cheng CT, et al
    Determinants of Breast-Conserving Therapy in Early-Stage Breast Cancer Patients: A Nationwide Study.
    Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00344.
    PubMed     Abstract available


  371. MAHTANI R, Oestreicher N, Lalla D, Ogbonnaya A, et al
    Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents.
    Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00349.
    PubMed     Abstract available


  372. VIUFF JH, Greiber IK, Karlsen MA, Storgaard L, et al
    Survival in Women Diagnosed With Breast Cancer During Pregnancy.
    Clin Breast Cancer. 2021 Dec 1. pii: S1526-8209(21)00346.
    PubMed     Abstract available


  373. LIN J, Hu H, Shriver CD, Zhu K, et al
    Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.
    Clin Breast Cancer. 2021 Dec 1. pii: S1526-8209(21)00348.
    PubMed     Abstract available


  374. FODOR A, Brombin C, Mangili P, Tummineri R, et al
    Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients.
    Clin Breast Cancer. 2021 Dec 1. pii: S1526-8209(21)00345.
    PubMed     Abstract available


  375. HARRIS EER
    Breast Radiation and the Heart: Cardiac Toxicity and Cardiac Avoidance.
    Clin Breast Cancer. 2021;21:492-496.
    PubMed     Abstract available


  376. GUO H, Idrovo JP, Cao J, Roychoudhury S, et al
    Human Papillomavirus (HPV) Detection by Chromogenic In Situ Hybridization (CISH) and p16 Immunohistochemistry (IHC) in Breast Intraductal Papilloma and Breast Carcinoma.
    Clin Breast Cancer. 2021;21:e638-e646.
    PubMed     Abstract available


  377. LISA A, Losurdo A, Testori A, Tinterri C, et al
    Comment on: "Oncologic Safety of Autologous Fat Grafting in Breast Reconstruction".
    Clin Breast Cancer. 2021;21:e693.
    PubMed    


  378. XU F, Li C, Li X, Huang Q, et al
    Competing-Risk Nomograms for Predicting the Prognosis of Patients With Infiltrating Lobular Carcinoma of the Breast.
    Clin Breast Cancer. 2021;21:e704-e714.
    PubMed     Abstract available


  379. VAN DE VOORT EMF, Struik GM, Birnie E, Moelker A, et al
    Thermal Ablation as an Alternative for Surgical Resection of Small (
    Clin Breast Cancer. 2021;21:e715-e730.
    PubMed     Abstract available


    November 2021
  380. CHIRADONI THUNGAPPA S, Maksud T, Raut N, Nagarkar R, et al
    Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic Breast Cancer: A Randomized, Open-Label, Multicent
    Clin Breast Cancer. 2021 Nov 27. pii: S1526-8209(21)00343.
    PubMed     Abstract available


  381. MULLANGI S, Vasan N
    Genomic Characterization of De Novo Metastatic Breast Cancer.
    Clin Breast Cancer. 2021 Nov 26. pii: S1526-8209(21)00342.
    PubMed     Abstract available


  382. AKINYEMIJU T, Oyekunle T, Salako O, Gupta A, et al
    Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study.
    Clin Breast Cancer. 2021 Nov 23. pii: S1526-8209(21)00320.
    PubMed     Abstract available


  383. WOOSTER M, McGuinness JE, Fenn KM, Singh VM, et al
    Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide Assay.
    Clin Breast Cancer. 2021 Nov 14. pii: S1526-8209(21)00318.
    PubMed     Abstract available


  384. LI GQ, Yao J, Zhou P, Chen DX, et al
    Distribution, Chemotherapy Use, and Outcome of the 21-Gene Recurrence Score Between Chinese and White breast Cancer in the United States.
    Clin Breast Cancer. 2021 Nov 14. pii: S1526-8209(21)00319.
    PubMed     Abstract available


  385. SHAHI S, Meza J, Tandra P, LeVan T, et al
    Gender Differences in Recommended Treatment Decisions among Breast Cancer Patients: A Study Using the National Cancer Database.
    Clin Breast Cancer. 2021 Nov 8. pii: S1526-8209(21)00307.
    PubMed     Abstract available


  386. SILVA DTC, Vanderlei LCM, Palma MR, Ribeiro FE, et al
    Association Between Different Domains of Physical Activity and Body Adiposity Indicators in Breast Cancer Survivors.
    Clin Breast Cancer. 2021 Nov 5. pii: S1526-8209(21)00306.
    PubMed     Abstract available


  387. KANESHIRO K, Kubo M, Taniguchi M, Yamada M, et al
    Current Status and Problems of Breast Cancer Treatment with Schizophrenia.
    Clin Breast Cancer. 2021 Nov 4. pii: S1526-8209(21)00297.
    PubMed     Abstract available


  388. XUE M, Che S, Tian Y, Xie L, et al
    Nomogram Based on Breast MRI and Clinicopathologic Features for Predicting Axillary Lymph Node Metastasis in Patients with Early-Stage Invasive Breast Cancer: A Retrospective Study.
    Clin Breast Cancer. 2021 Nov 1. pii: S1526-8209(21)00305.
    PubMed     Abstract available


    October 2021
  389. LI W, Hu S, Han Z, Jiang X, et al
    YY1-Induced Transcriptional Activation of FAM111B Contributes to the Malignancy of Breast Cancer.
    Clin Breast Cancer. 2021 Oct 29. pii: S1526-8209(21)00298.
    PubMed     Abstract available


  390. YARDLEY DA, Young RR, Adelson KB, Silber AL, et al
    A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC).
    Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00302.
    PubMed     Abstract available


  391. BOLUKBASI Y, Oymak E, Sezen D, Onal C, et al
    Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Mono-Institutional Study: In Regard to De Matteis et al.
    Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00303.
    PubMed    


  392. MEANS-POWELL JA, Mayer IA, Ismail-Khan R, Del Valle L, et al
    A Phase Ib Dose Escalation Trial of RO4929097 (a gamma-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC).
    Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00304.
    PubMed     Abstract available


  393. MILTON L, Behroozian T, Li N, Zhang L, et al
    Symptom Burden Associated With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy.
    Clin Breast Cancer. 2021 Oct 13. pii: S1526-8209(21)00296.
    PubMed     Abstract available


  394. MO H, Renna CE, Moore HCF, Abraham J, et al
    Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors.
    Clin Breast Cancer. 2021 Oct 9. pii: S1526-8209(21)00293.
    PubMed     Abstract available


  395. CONTE B, Soldato D, Razeti MG, Fregatti P, et al
    De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence.
    Clin Breast Cancer. 2021 Oct 8. pii: S1526-8209(21)00292.
    PubMed     Abstract available


  396. BENOIT L, Cambra C, Rouzier R, Cottu P, et al
    Quality of Life in an e-Cohort of Women Treated by Endocrine Therapy for Early Breast Cancer.
    Clin Breast Cancer. 2021 Oct 1. pii: S1526-8209(21)00291.
    PubMed     Abstract available


  397. DUDLEY CM, Wiener AA, Stankowski-Drengler TJ, Schumacher JR, et al
    Rates of Ipsilateral Local-regional Recurrence in High-risk Patients Undergoing Immediate Post-mastectomy Reconstruction (AFT-01).
    Clin Breast Cancer. 2021;21:433-439.
    PubMed     Abstract available


  398. HSIEH K, Housri N, Haffty B, Smith B, et al
    Radiation Oncologists' Views on Breast Radiation Therapy Guidelines: Utilizing an Online Q&A Platform to Assess Current Views on Whole-Breast Irradiation Therapy.
    Clin Breast Cancer. 2021;21:408-416.
    PubMed     Abstract available


  399. DAVIS J JR, Boughey JC, Hoskin TL, Day CN, et al
    Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.
    Clin Breast Cancer. 2021;21:458-465.
    PubMed     Abstract available


  400. VARTHOLOMATOS G, Harissis H, Andreou M, Tatsi V, et al
    Rapid Assessment of Resection Margins During Breast Conserving Surgery Using Intraoperative Flow Cytometry.
    Clin Breast Cancer. 2021;21:e602-e610.
    PubMed     Abstract available


  401. CARTAGENA LC, McGuire K, Zot P, Pillappa R, et al
    Breast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization.
    Clin Breast Cancer. 2021;21:e594-e601.
    PubMed     Abstract available


  402. WU JM, Turashvili G
    A Survey of Breast Pathologists' Practice in Staging Multiple Foci of Invasive Carcinoma.
    Clin Breast Cancer. 2021;21:e506-e511.
    PubMed     Abstract available


    September 2021
  403. GULER OC, Onal C
    Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients with Pathologic Negative Nodes after Neoadjuvant Chemotherapy. In regard to Schlafstein et al.
    Clin Breast Cancer. 2021 Sep 29. pii: S1526-8209(21)00288.
    PubMed    


  404. JIA H, Zheng Y, Wang P, Wei Z, et al
    A Retrospective Study on the Clinicopathologic Characteristics and Outcomes of 179 Cases of Synchronous and Metachronous Bilateral Breast Cancer in China.
    Clin Breast Cancer. 2021 Sep 29. pii: S1526-8209(21)00289.
    PubMed     Abstract available


  405. DE MATTEIS S, Facondo G, Valeriani M, Vullo G, et al
    Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study.
    Clin Breast Cancer. 2021 Sep 25. pii: S1526-8209(21)00266.
    PubMed     Abstract available


  406. SEALE KN, Tkaczuk KHR
    Circulating Biomarkers in Breast Cancer.
    Clin Breast Cancer. 2021 Sep 22. pii: S1526-8209(21)00264.
    PubMed     Abstract available


  407. JUNG L, Miske A, Indorf A, Nelson K, et al
    A Retrospective Analysis of Metronomic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Docetaxel and Cyclophosphamide (TC) as Adjuvant Treatment in Early Stage, Hormone Receptor Positive, HER2 Negative Breast Cancer.
    Clin Breast Cancer. 2021 Sep 22. pii: S1526-8209(21)00265.
    PubMed     Abstract available


  408. BARLUND M, Takala L, Tianen L, Kellokumpu-Lehtinen PL, et al
    Real-world Evidence of Implementing eHealth Enables Fluent Symptom-based Follow-up of a Growing Number of Patients with Breast Cancer with the Same Healthcare Resources.
    Clin Breast Cancer. 2021 Sep 20. pii: S1526-8209(21)00263.
    PubMed     Abstract available


  409. SAKACH E, O'Regan R, Meisel J, Li X, et al
    Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies.
    Clin Breast Cancer. 2021 Sep 17. pii: S1526-8209(21)00261.
    PubMed     Abstract available


  410. LEVASSEUR N, Sun J, Fenton D, Baxter S, et al
    Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study.
    Clin Breast Cancer. 2021 Sep 17. pii: S1526-8209(21)00262.
    PubMed     Abstract available


  411. LI Y, Lin Q, Lu X, Li W, et al
    Post-Diagnosis use of Antioxidant Vitamin Supplements and Breast Cancer Prognosis: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2021 Sep 12. pii: S1526-8209(21)00259.
    PubMed     Abstract available


  412. RAO MALLA R, Marni R, Kumari S, Chakraborty A, et al
    Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer.
    Clin Breast Cancer. 2021 Sep 12. pii: S1526-8209(21)00260.
    PubMed     Abstract available


    August 2021
  413. LI J, Li Y, Cheng H
    Circ-RPPH1 knockdown retards breast cancer progression via miR-328-3p-mediated suppression of HMGA2.
    Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00247.
    PubMed     Abstract available


  414. RIBATTI D, Annese T, Tamma R
    Controversial role of mast cells in breast cancer tumor progression and angiogenesis.
    Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00246.
    PubMed     Abstract available


  415. ZHU J, Zheng H, Ge C, Lin H, et al
    Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer.
    Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00245.
    PubMed     Abstract available


  416. SINCLAIR WD, Cui X
    The Effects of HER2 on CDK4/6 Activity in Breast Cancer.
    Clin Breast Cancer. 2021 Aug 26. pii: S1526-8209(21)00244.
    PubMed     Abstract available


  417. LORUSSO P, Hamilton E, Ma C, Vidula N, et al
    A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer.
    Clin Breast Cancer. 2021 Aug 20. pii: S1526-8209(21)00240.
    PubMed     Abstract available


  418. LI Q, Wang K, Yang L, Wu Q, et al
    Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study.
    Clin Breast Cancer. 2021;21:360-372.
    PubMed     Abstract available


  419. HADADI I, Rae W, Clarke J, McEntee M, et al
    Diagnostic Performance of Adjunctive Imaging Modalities Compared to Mammography Alone in Women with Non-Dense and Dense Breasts: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2021;21:278-291.
    PubMed     Abstract available


  420. SHAMOUN F, Asaad M, Hanson SE
    Oncologic Safety of Autologous Fat Grafting in Breast Reconstruction.
    Clin Breast Cancer. 2021;21:271-277.
    PubMed     Abstract available


  421. SALGARELLO M, Pagliara D, Barone Adesi L, Visconti G, et al
    Direct to Implant Breast Reconstruction With Prepectoral Micropolyurethane Foam-Coated Implant: Analysis of Patient Satisfaction.
    Clin Breast Cancer. 2021;21:e454-e461.
    PubMed     Abstract available


  422. AFSHARFARD A, Ebrahimibagha H, Zeinalpour A
    A Novel Local Transposition Flap for Lateral Breast Reconstruction After Breast Conserving Surgery.
    Clin Breast Cancer. 2021;21:e448-e453.
    PubMed     Abstract available


  423. YAMASHITA Y, Tsunoda H, Nagura N, Kajiura Y, et al
    Long-Term Oncologic Safety of Nipple-Sparing Mastectomy With Immediate Reconstruction.
    Clin Breast Cancer. 2021;21:352-359.
    PubMed     Abstract available


  424. MENG X, Ma H, Yin H, Yin H, et al
    Nomogram Predicting the Risk of Locoregional Recurrence After Mastectomy for Invasive Micropapillary Carcinoma of the Breast.
    Clin Breast Cancer. 2021;21:e368-e376.
    PubMed     Abstract available


  425. GOYAL U, Saboda K, Roe D, Gonzalez VJ, et al
    Prone Positioning With Deep Inspiration Breath Hold for Left Breast Radiotherapy.
    Clin Breast Cancer. 2021;21:e295-e301.
    PubMed     Abstract available


  426. CAPUTO GG, Zingaretti N, Kiprianidis I, Zanfisi C, et al
    Quality of Life and Early Functional Evaluation in Direct-to-Implant Breast Reconstruction After Mastectomy: A Comparative Study Between Prepectoral Versus Dual-Plane Reconstruction.
    Clin Breast Cancer. 2021;21:344-351.
    PubMed     Abstract available


    July 2021
  427. TOORANG F, Sasanfar B, Esmaillzadeh A, Zendehdel K, et al
    Adherence to the DASH Diet and Risk of Breast Cancer.
    Clin Breast Cancer. 2021 Jul 31. pii: S1526-8209(21)00198.
    PubMed     Abstract available


    June 2021
  428. FORTUNATO L, Loreti A, Cortese G, Spallone D, et al
    Regret and Quality of Life After Mastectomy With or Without Reconstruction.
    Clin Breast Cancer. 2021;21:162-169.
    PubMed     Abstract available


  429. ABOUELAZAYEM M, Elkorety M, Monib S
    Breast Lymphedema After Conservative Breast Surgery: An Up-to-date Systematic Review.
    Clin Breast Cancer. 2021;21:156-161.
    PubMed     Abstract available


  430. BRUNO E, Oliverio A, Paradiso A, Daniele A, et al
    Lifestyle Characteristics in Women Carriers of BRCA Mutations: Results From an Italian Trial Cohort.
    Clin Breast Cancer. 2021;21:e168-e176.
    PubMed     Abstract available


  431. JAFFERBHOY SF, Goussous G, Chandarana M, Salehi-Bird S, et al
    Impact of Preoperative MRI in Invasive Ductal Carcinoma With Lobular Features on Core Biopsy.
    Clin Breast Cancer. 2021;21:e194-e198.
    PubMed     Abstract available


  432. LONG R, Cao K, Cao M, Li XT, et al
    Improving the Diagnostic Accuracy of Breast BI-RADS 4 Microcalcification-Only Lesions Using Contrast-Enhanced Mammography.
    Clin Breast Cancer. 2021;21:256-262.
    PubMed     Abstract available


  433. KIM H, Vargo JA, Smith KJ, Beriwal S, et al
    Cost-Effectiveness Analysis of Biological Signature DCISionRT Use for DCIS Treatment.
    Clin Breast Cancer. 2021;21:e271-e278.
    PubMed     Abstract available


  434. DE OLIVEIRA-JUNIOR I, Brandini da Silva FC, Nazima F, Ribeiro JC Jr, et al
    Oncoplastic Surgery: Does Patient and Medical Specialty Influences the Evaluation of Cosmetic Results?
    Clin Breast Cancer. 2021;21:247-255.
    PubMed     Abstract available


  435. NAIR NS, Chitkara G, Hawaldar RW, Parmar V, et al
    En Bloc Excision of Phyllodes Tumor of the Breast: Radical Approach Heralds Better Outcome.
    Clin Breast Cancer. 2021;21:e228-e234.
    PubMed     Abstract available


  436. COBB AN, Janjua HM, Kuo PC
    Big Data Solutions for Controversies in Breast Cancer Treatment.
    Clin Breast Cancer. 2021;21:e199-e203.
    PubMed     Abstract available


  437. ANDRIKOPOULOU A, Zografos E, Liontos M, Koutsoukos K, et al
    Trastuzumab Deruxtecan (DS-8201a): The Latest Research and Advances in Breast Cancer.
    Clin Breast Cancer. 2021;21:e212-e219.
    PubMed     Abstract available


  438. BILANI N, Elson L, Liang H, Elimimian EB, et al
    Effect of Surgery at Primary and Metastatic Sites in Patients With Stage IV Breast Cancer.
    Clin Breast Cancer. 2021;21:170-180.
    PubMed     Abstract available


  439. SUN J, Henry DA, Carr MJ, Yazdankhahkenary A, et al
    Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization.
    Clin Breast Cancer. 2021;21:e189-e193.
    PubMed     Abstract available


    April 2021
  440. WISINSKI K, O'Regan R
    Introduction to Special Issue.
    Clin Breast Cancer. 2021;21:95.
    PubMed    


  441. MONTAGNA G, Morrow M
    Breast-conserving Surgery Without Radiation Therapy for Invasive Cancer.
    Clin Breast Cancer. 2021;21:112-119.
    PubMed     Abstract available


  442. HEPEL JT, Wazer DE
    Update on Partial Breast Irradiation.
    Clin Breast Cancer. 2021;21:96-102.
    PubMed     Abstract available


    February 2021
  443. ERNST A, Flynn KE, Weil EM, Crotty BH, et al
    Aromatase Inhibitor Symptom Management Practices: A Retrospective Study.
    Clin Breast Cancer. 2021;21:e38-e47.
    PubMed     Abstract available


  444. INUZUKA M, Watanabe C, Yokoyama S, Kuwayama T, et al
    A Retrospective Analysis of the Relationship Between the Result of BRCA1/2 Genetic Testing and Surgical Method Selection in Japan.
    Clin Breast Cancer. 2021;21:e48-e52.
    PubMed     Abstract available


  445. SAVVA C, Sadiq M, Sheikh O, Karim S, et al
    Werner Syndrome Protein Expression in Breast Cancer.
    Clin Breast Cancer. 2021;21:57-73.
    PubMed     Abstract available


  446. JOHN P, Osani MC, Kodali A, Buchsbaum R, et al
    Comparative Effectiveness of Adjuvant Chemotherapy in Early-Stage Breast Cancer: A Network Meta-analysis.
    Clin Breast Cancer. 2021;21:e22-e37.
    PubMed     Abstract available


  447. MATHIAS BJ, Sun J, Sun W, Zhou JM, et al
    Surgeon Bias in the Management of Positive Sentinel Lymph Nodes.
    Clin Breast Cancer. 2021;21:74-79.
    PubMed     Abstract available


  448. PATEL BK, Samreen N, Zhou Y, Chen J, et al
    MR Elastography of the Breast: Evolution of Technique, Case Examples, and Future Directions.
    Clin Breast Cancer. 2021;21:e102-e111.
    PubMed     Abstract available


  449. GOFF SL, Danforth DN
    The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer.
    Clin Breast Cancer. 2021;21:e63-e73.
    PubMed     Abstract available


  450. EARLY AP, Moon W
    Breast Cancer and Secondary Cancer Recurrences After Autologous Tissue Reconstruction.
    Clin Breast Cancer. 2021;21:e96-e101.
    PubMed     Abstract available


  451. GADDAM S, Heller SL, Babb JS, Gao Y, et al
    Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing.
    Clin Breast Cancer. 2021;21:e74-e79.
    PubMed     Abstract available


  452. RUIZ-CASADO A, Alvarez-Bustos A, de Pedro CG, Mendez-Otero M, et al
    Cancer-related Fatigue in Breast Cancer Survivors: A Review.
    Clin Breast Cancer. 2021;21:10-25.
    PubMed     Abstract available


  453. MCDONOUGH AL, Lei Y, Kwak AH, Haggett DE, et al
    Implementation of a Brief Screening Tool to Identify Needs of Breast Cancer Survivors.
    Clin Breast Cancer. 2021;21:e88-e95.
    PubMed     Abstract available


  454. TUFANO AM, Teplinsky E, Landry CA
    Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer.
    Clin Breast Cancer. 2021;21:1-9.
    PubMed     Abstract available


  455. KIM DW, Kim JS, Kim K, Shin KH, et al
    Spontaneous Rib Fractures After Breast Cancer Treatment Based on Bone Scans: Comparison Of Conventional Versus Hypofractionated Radiotherapy.
    Clin Breast Cancer. 2021;21:e80-e87.
    PubMed     Abstract available


  456. SAYAN M, Vergalasova I, Jhawar S, Kumar S, et al
    Utilization of Hypofractionated Whole-Breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.
    Clin Breast Cancer. 2021;21:31-36.
    PubMed     Abstract available


  457. PARIS I, Di Giorgio D, Carbognin L, Corrado G, et al
    Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach.
    Clin Breast Cancer. 2021;21:e120-e127.
    PubMed     Abstract available


  458. WAN C, Williams CP, Nipp RD, Pisu M, et al
    Treatment Decision Making and Financial Toxicity in Women With Metastatic Breast Cancer.
    Clin Breast Cancer. 2021;21:37-46.
    PubMed     Abstract available


  459. TSAI ML, Knaack M, Martone P, Krueger J, et al
    Effects of Germline Pathogenic Variants, Cancer Subtypes, Tumor-related Characteristics, and Pregnancy-associated Diagnosis on Outcomes.
    Clin Breast Cancer. 2021;21:47-56.
    PubMed     Abstract available


  460. VILLASCO A, Agnelli F, D'Alonzo M, Accomasso F, et al
    Validation of CTS5 on a Retrospective Cohort of Real-Life Pre- and Postmenopausal Patients Diagnosed With Estrogen Receptor-Positive Breast Cancers: Is It Prognostic?
    Clin Breast Cancer. 2021;21:e53-e62.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.